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MOLECULAR BASIS OF THE ROLE OF KINDLIN 2 IN CELL 
ADHESION 
 
H. DHANUJA D. PERERA 
 
ABSTRACT 
 
Kindlins are a novel family of cytoskeleton proteins that plays an important role 
in the activation of heterodimeric integrin transmembrane receptors. These receptors play 
a vital role in cell adhesion, cell migration and other cellular processes. The Kindlin 
protein family consists of three homologous proteins, Kindlin 1, 2 and 3 with differential 
tissue distribution and varying expression levels in human. Mutations of Kindlin 1 
protein are clinically linked to Kindler Syndrome. Kindlin 2 knockdown studies have 
shown embryonic lethality in mouse, but no diseases have been clinically testified. 
Kindlin 3 mutations are associated with bleeding disorders, e.g. LADIII.  
Talin is a cytoskeleton protein, which is a well known and widely studied 
activator of integrin receptors.  Talin and Kindlin bind to non-overlapping binding sites 
on integrin β3 cytoplasmic tail. Their cooperation significantly enhances integrin 
activation compared to integrin activation by Talin activity itself. Kindlin and Talin share 
similar structural homology. A unique feature in the Kindlin FERM domain compared to 
the FERM domain of Talin is that the FERM domain of Kindlin is split by a PH domain.  
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The main focus of the study was to understand the role of Kindlin 2 in the 
complex process of integrin activation. To gain structural insight, we have determined the 
3D structure of Kindlin 2 N-terminal F0 domain by using Nuclear Magnetic Resonance 
Spectroscopy. More than 90% of the backbone and side chain NMR resonances have 
been assigned. Kindlin 1 and 2 F0 domains share 62% sequence homology and have a 
similar ubiquitin-like beta grasp fold. However, there are distinct differences between 
Kindlin 1 and 2 F0 domain structures, which may contribute to functional differences. An 
in vivo assay has shown that deletion of the F0 domain from the Kindlin 2 full length 
protein abolishes integrin activation. Thus, Kindlin 2 F0 domain plays a significant role 
in integrin activation. Our in vitro data have shown a very weak interaction between 
Kindlin 2 F0 domain and integrin β3 cytoplasmic tail /membrane/PIP. In addition, we 
measured a 1µM affinity for Kindlin 2 PH domain and PIP3 interaction. Altogether these 
data suggest that both the F0 and PH domains of Kindlin 2 interact with the membrane 
surface and facilitate the effect of Kindlin 2 in integrin activation. 
Besides Talin and Kindlin, the focal adhesion protein Migfilin, also promotes 
integrin activation. It has been reported that the C terminally located LIM domains of 
Migfilin, bind predominantly to Kindlin N-terminal region. We have tested the 
interaction between Kindlin 2 N-terminus and Migfilin LIM domain proteins. Our data 
show a weak interaction between 11-143 fragment and Migfilin LIM23 domain of 
Migfilin. Though Kindlin, Talin and Migfilin are likely to be spatially close during 
integrin activation, here we have eliminated the interaction between Migfilin-Talin H and 
Kindlin F0-Talin H domains.   
 ix
In summary, the N-terminally located F0 domain of Kindlin 2 is crucial for 
integrin activation. The interactions of the F0 and PH domains of Kindlin 2 with the 
membrane suggest a role in anchoring to the membrane surface. The N-terminal 11-143 
residues of Kindlin 2 are necessary for the interaction with Migfilin LIM domain. 
Overall, the N-term region of Kindlin 2 plays a key role in the complex process of 
integrin activation.  
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CHAPTER I 
 
INTRODUCTION 
 
1.1 Integrins 
Integrins are transmembrane cell adhesion receptors mediating cell-cell adhesion, 
cell migration and other cellular processes. They are present in all metazoans but not 
found in the kingdom plantae and fungi (Hynes et al., 2002). Integrins are heterodimeric 
receptors formed by an α subunit and a β subunit which are non-covalently linked to each 
other. Each subunit has 3 distinctive structural regions: The ectodomain, a short 
transmembrane helix and the cytoplasmic peptide tail (Barczyk et al., 2000). The Integrin 
ectodomain exists in two conformations: the bent conformation and the extended 
conformation. In the bent conformation the subdomains of the integrin ectodomain are 
more compact and the ligand binding site is faced towards the plasma membrane. This 
conformation holds integrin in a low affinity state for ligand binding. In the extended 
conformation the subdomains of the ectodomain of integrin are less compact and the 
ligand binding site is faced towards the extra cellular matrix of the cell. This 
conformation has a high affinity for ligand binding and is also termed activated integrins.  
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In vertebrates the integrin receptor family consists of 24 members that are formed by 18 α 
and 8 β subunits (Takada et al., 2007). These are grouped into four categories based on 
ligand binding receptors: RGD receptors, Collagen receptors, Laminin receptors and 
Leukocyte specific receptors (Figure 1.1).  
 
Figure 1.1. Types of Integrin Receptors. Adopted from (Hynes et al., 
2002). In mammals, 18 alpha and 8 beta subunits are assembled in to 24 
different heterodimers. Integrins are the main receptors for ECM proteins, 
they can also bind to other components like receptors (ICAMs, VCAM), 
molecules like fibrinogen and pathogens (e.g. viruses and bacteria).There 
are different integrin subfamilies based on sequences, binding properties / 
expression patterns: RGD-binding integrins in blue, the laminin-binding 
integrins in purple, the leukocyte integrins in yellow, collagen binding 
receptors in grey. 
 
The 24 different types of integrin receptors have varying degrees of expression 
and some have tissue specificity. For example, Integrin αIIbβ3 is present on platelet 
membrane surface and recognizes fibronectins and fibrinogen. Its interaction is linked to 
platelet aggregation and wound healing. α6β4 integrins are present on epithelial cell 
surface and specifically binds to laminin. 
 3
Integrin cytoplasmic tail (CT) is crucial for integrin signaling (Vinogradava, O. et 
al., 2002 and others). The CT tails of the α and β subunits of integrin receptors have 
conserved amino acid sequences among different members within the group 
(Calderwood, 2004). Two NPxY motifs are present in almost all cytoplasmic tail 
sequences of the β subunit, except in integrin β2, which has two NPxF motifs. The first 
NPxY747 motif of integrin β3 is important for Talin interaction and the second NPxY759 
motif interacts with Kindlin. This interaction is the hallmark for subsequent activation of 
integrins.   
Integrins are the largest group of cell adhesion receptor. In addition to cell 
signaling, integrins also play a central role in many cellular processes. Dysfunction of 
integrins has reported to cause severe embryonic malformation (Keller et al., 2001; 
Martin-Bermudo et al., 1998). The function of integrin is crucial for proper homeostasis 
and its regulation has been linked to many diseases such as cancer and atherosclerosis. A 
large effort has been made to develop therapeutic drugs that directly target integrins 
(Cox,  et. al., 2010). 
 
1.2. Integrin Activation and Signaling 
During the process of integrin activation, integrins undergo a conformational 
transition from a bent conformation to the extended conformation. Integrin associated 
signaling is bi-directional, inside-out and outside-in signaling. A large number of proteins 
are associated with the integrin in-side out signaling mechanism. As mentioned earlier, 
Kindlin and Talin directly regulate integrin activation. In addition, other proteins like 
 4
Filamin, ILK, CIB and Migfilin are also involved in tight regulation of the integrin 
inside-out signaling mechanism.  
At the resting state or inactive state of integrins, the interaction between the CT of 
the αIIb and β3 subunits form a clasp that holds integrin at its inactive conformation. 
Structural studies revealed that the PTB domain of Talin binds to the NPxY474 motif near 
the membrane-proximal region of the integrin β3 CT (Vinogradova et al., 2002; Garcia-
Alvarez et al., 2003; Wegener et al., 2007; Yang et al., 2009). This binding eventually 
disrupts the membrane-proximal clasp that holds the αIIb and β3 subunits together. This 
process transforms the ectodomain of integrin from a bent to an extended conformation 
which has a high affinity for ligand binding (Calderwood et al., 2002; Garcia-Alvarez et 
al., 2003; Qin et al., 2004). Interestingly, most recent studies have revealed that the 
 
Figure 1.2. Integrin activation. Adopted from Y-Q. Ma, J. Qin and E. F. 
Plow, 2007. 
 
interaction between integrin β CT and Talin is not sufficient to activate integrins at its full 
activation potential. Other proteins like Kindlin act as co-activators in Talin induced 
integrin activation resulting in a significant increase in integrin activation (Shi et al., 
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2007). The PTB domain in Kindlin 2 F3 subdomain interacts with the distal NxxY759 
motif of the integrin β3 CT and the coordinated interaction of both Kindlin and Talin 
with the integrin CT has shown to lead to an increased activation of integrins (Ma et al., 
2008; Montanez et al., 2008). 
Once activated, integrins bind to extracellular matrix (ECM) ligands and transmit 
signals from the extracellular matrix (ECM) to the cell interior. This pathway is the 
outside-in signaling. Despite decades of studies on integrin signaling, the mechanism of 
integrin activation is still not clearly understood. Not much is known about the detailed 
mechanism of inside-out signaling and specifically how Kindlin and Talin cooperate to 
induce potent integrin activation. We are interested in understanding the role of Kindlin 
in the process of Talin induced integrin activation. 
 
1.3. Focal adhesion 
Focal adhesions are multimeric and dynamic protein complexes assembled around 
activated integrins/integrin clusters which link the ECM and the cytoskeleton of the cell.  
There are four levels of grouping based on factors like composition, localization and size: 
focal complexes, focal adhesions, fibrillar adhesions and matrix adhesions. Each has a 
distinct role in cells such as cell migration, cell-cell adhesion, cell proliferation, cell 
differentiation etc. (Wozniak et al., 2004). This thesis investigates the role of key focal 
adhesion proteins, integrin β3 CT, Kindlin, Migflin and Talin with particular focus on 
Kindlin. 
 
 
 6
1.4. Kindlins 
Kindlins are a relatively novel group of cytoplasmic proteins. They have gained 
much attention for their roles in disease development. More recently, accumulating data 
for their role in integrin activation has become an area of interest (Goult et al., 2009; 
Harburger et al., 2009; Larjava et al., 2008; Ma et al., 2008; Montanez et al., 2008; Moser 
et al., 2008; Ussar et al., 2006).  However, not much is known about the structural details 
of Kindlins or its role in integrin activation. 
 
1.4.1. Kindlin protein family 
The Kindlin protein family in human consists of three homologous proteins, 
Kindlin 1, 2 and 3.  Kindlin 1 was the first to be identified by Siegel et al. This group 
further identified two additional Kindlin 1 like proteins, MIG-2 and MGC10966, which 
they renamed as Kindlin 2 and Kindlin 3 respectively (Siegel et al., 2003). The first 
Kindlin ortholog to be identified was UNC-112 in C. elegans. All Kindlin proteins and 
UNC-112 share common features in their domain structure and amino acid sequences.  
 
 
Figure 1.3. Kindlin-1 protein structural domains.(Goult et al., 2009). 
Kindlin 1 and 3 proteins have similar structural domains. The F2 subdomain 
is split by a PH domain, the F0 domain is located at the very N-terminus and 
the F3 subdomain at the C-terminus. 
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All Kindlin proteins have a FERM domain and a N-terminally located F0 domain. A 
unique feature of Kindlin FERM domain compared to other FERM domains of all other 
proteins is that the F2 subdomain of the FERM is split by the PH domain (Fig 1.3). To 
date the structure of F0 subdomain of Kindlin 1 has been elucidated by Goult et al. (Goult 
et al., 2009).  
PH domains (Plekstrin Homolgy domain) are present in many proteins. They are 
known to bind to phosphoinositides with specificities to the inositol ring, helping in 
localizing proteins to the membrane surface and involving in regulatory mechanisms. PH 
domains that bind to G proteins and protein kinase C are part of signal transduction 
pathways (Shaw, G., 1996). The role of the PH domain of Kindlin is not yet known.  
FERM domains are evolutionary conserved structural domains which serve in 
various cellular signaling mechanisms. They consist of 3 subdomains, F1, F2 and F3. 
FERM domains are found in many proteins and bind with specificities to 
phosphoinositides. Both Talin and Kindlin have FERM domains. The F3 subdomain of 
Kindlin and Talin show similar homologies and are known to bind to non-overlapping 
sites of integrin β3 cytoplasmic tails. Talin F3 subdomain binds to phosphoinositides and 
its interaction activates Talin for subsequent interaction with integrin CT (Goksoy et al., 
2009). The interaction between Kindlin F3 subdomain and phophoinositides remains for 
potential investigation.  
Kindlin proteins are encoded from 3 different chromosomes. Kindlin 1 from 
chromosome 20, Kindlin 2 from chromosome 14 and Kindlin 3 from chromosome 11 
(Weinstein et el., 2003). 
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Kindlin 1 or FERMT1 is 677 residues in length and has a molecular mass of 77.3 KDa. 
Siegel et al. group have first demonstrated that Kindlin co localizes with vinculin in focal 
contacts. Kindlin 1 is a phosphoprotein where the serine residues at position 170 and 179 
are phosphorylated (Dephoure N., et al., 2008). There are four isoforms described in 
Kindlin 1 protein but their individual functions are not known 
(http://www.uniprot.org/uniprot/Q9BQL6). 
Kindlin 2 is a 68KDa protein and is 680 amino acids in length.  It displays 60% sequence 
identity to Kindllin 1 and 49% sequence identity to Kindlin 3. Human Kindlin 2 two exist 
in two isoforms produced by alternative splicing 
(http://www.uniprot.org/uniprot/Q96AC1). Isoform 1 is considered as the canonical 
sequence. Kindlin 2 isoform has certain differences at the C terminus: residues 627-680 
are missing, residues 625-626 are TV→NS and residue 534 is an insertion of 
Q→QPGYIRDL. Phosphorylation of serine residues at position 159, 181 and 666 of the 
sequence have been identified in Kindlin 2 (Ussar et al., 2006). A unique feature of 
Kindlin 2 sequence among other Kindlin proteins is the nuclear localization signal (NLS), 
which spans between 152-172 amino acid region.  
Kindlin 3 is 677 residues in length and is widely known as FERMT3. Kindlin 3 is 
expressed in the hematopoitic tissues and plays a fundamental role in cell adhesion, 
integrin activation, wound healing etc. Kindlin 3 is also found as two isoforms in human, 
(http://www.uniprot.org/uniprot/Q86UX7) residues 360-363 in isoform 2 are missing 
from isoform 1 sequence. Post-translational phosphorylations are identified at positions 8, 
11 and 504 of the sequence.   
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1.4.2. Diseases associated with Kindlins. 
Kindler syndrome is a rare but severe skin condition, which is caused by 
autosomal recessive genes of KIND1 mutation/s. It is the first skin disorder, which has 
been identified to occur due to a non-systematic connection of the cell between the extra 
cellular matrix and actin cytoskeleton (Siegel et al., 2003). Major symptoms appear to be 
skin blistering due to skin fragility, sensitivity to the exposure of the sun, unusual 
melanin distribution and wrinkling of the skin. Altogether the individual shows a 
prematurely aged appearance at early childhood (Theresa Kindler in 1954).  
To date there are no diseases related to Kindlin 2 mutations. Kindlin 2 knock 
down mice are embryonicaly lethal heightening the significance of Kindlin 2 during 
embryogenesis. In fact Kindlin 2, among other Kindlin proteins plays a central role in 
early cardiogenesis (Mackinnon et al., 2002; Williams and Waterston, 1994; Xu et al., 
2006). Its crucial role might not be completed with impaired functions of the protein.  
LAD-III is a leukocyte adhesion deficiency syndrome and is linked to Kindlin 3 
mutations. Patients with LAD-III have an extended bleeding time and show a lack of 
ability of leukocytes to bind to the ECM.  
Despite a lot of studies have focused on diseases associated with Kindlins, not 
much is known about the disease pathologies. Even less is known about the particular 
functions and structure of Kindlin proteins.  
 
1.4.3. Tissue Distribution and Biological Roles of Kindlins. 
Kindlins are widely expressed in the human body. Ussar et al. have shown the 
distribution of Kindlin proteins in adult and embryonic mouse. Kindlin 3 expression is 
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found in all hematopoetic tissues: spleen, thymus, lymph node, and lungs (Fig 1.4.). 
Mouse Kindlin 2 RNA expression was observed in all tissue types with a high level of 
expression in heart, lung, skeletal muscle, bladder, stomach and kidney. Kindlin 1 
showed a higher expression of RNA levels in the colon, and bladder compared to a 
weaker expression in the skin, intestine and kidney. The expression of Kindlin 1 protein 
in the dermis of the skin is much weaker than in the expression of the epidermis, whereas 
the reverse is true for Kindlin 2 expression. Interestingly, malfunction of Kindlin 1 in the 
epidermis cannot be compensated by epidermal Kindlin 2 or with dermal Kindlin 1. This 
implies different functions of Kindlin 1 and 2 in the epidermis, and is the underlying 
cause for the Kindler Syndrome (Ussar et al., 2003). Another study has shown that 
Kindlin proteins have different sub cellular localization (Bailkowska et al., 2010). 
In addition to differential tissue expression, cancer cells also report an increased 
expression of Kindlin 2 protein. Kindlin 2 was up regulated in the nucleus of cancer cells 
suggesting that Kindlin 2 plays a major role in tumor growth (An et al., 2010b; Wu, 
2005).  
A recent study by Has, C. et al. revealed a role in Kindlin2 in adult skin tissue. 
Kindlin 2 is strongly up-regulated during wound healing of the human skin. It has shown 
to initiate integrin clustering and activation in fibroblasts cells, subsequently regulating 
the formation and maturation of focal adhesions and reorganization of the actin 
cytoskeleton (He et al., 2010). In myocytes, Kindlin 2 localizes to Z-discs of 
cardiomyocytes (Ussar et al., 2006). 
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Figure 1.4. Tissue distribution of Kindlin proteins. Adopted from (Ussar et 
al., 2006). 
 
1.4.4. Binding partners of Kindlin.  
There are three groups of proteins been identified in literature that interacts with 
Kindlin (An et al., 2010a). They are integrin β1, β2, β3 cytoplasmic tails, ILK and 
Migfilin.  
Integrin β1, β2 and β3 
 Using keratinocytes from normal and Kindler Syndrome patients, Siegel et al. 
have first demonstrated that there is a direct correlation between Kindlin 1 and integrin 
β1 activation (Siegel et al., 2003). Kindlin 1 protein has shown to bind directly to β1 and 
β3 integrins (Harburger et al., 2009)(Ussar et al., 2008). The FERM domain of Kindlin 1 
and 2 is sufficient for the interaction with integrin β CT (Harburger et al., 2009; Shi and 
Wu, 2008). Within the FERM domain, the F3 subdomain is important for the interaction 
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with integrin. Mutations of residue K610, W612 and L651 to Alanine in Kindlin 1 completely 
suppress the interaction to integrin β1 tail. In Kindlin 2, the mutation of W615 showed a 
dramatic effect on β3 interaction and subsequent integrin activation (Ma et al., 2008). 
Recent studies have shown that tyr795
 
phophorylation has a low affinity for Kindlin 2 
binding. These data suggest a regulatory mechanism of Kindlin 2 in integrin activation 
(Bledzka, K. et al., 2010). In addition, Kindlin 3 has shown to bind to β2 integrin on 
neutrophils and promotes integrin activation (Moser et al., 2009).  
Kindlin and Talin bind to different regions of the integrin CT and promote 
integrin activation. But how exactly these two binding events promote integrin activation 
remains elusive.  
Migfilin. 
Migfilin protein was first identified as a Kindlin binding protein (Tu et al., 2003). 
Migfilin, also known as Cal (Akazawa et al., 2004) or FBLP-1A (Takafuta et al., 2003), 
is a 367 amino acid protein. It has central proline rich region, an unstructured N-terminal 
region and three C-terminal LIM domains. There are three homologous Migfilin proteins 
in human (Figure 1.5). The Migfilin(s) homolog lacks the proline rich region in its 
structure, whereas the FBLP-1 lacks the LIM 3 domain. Migfilin has multiple binding 
partners; the LIM domains of Migfilin mediate the interaction between Migfilin and 
Kindlin 2. This interaction is required for the recruitment of Migfilin to the focal 
adhesions. The N-terminal region of Migfilin binds to Filamin and inhibits the negative 
regulatory effect of Filamin in integrin activation (Kiema et al., 2006; Ithychanda et al., 
2009a; Wu, 2005). Src is a protein kinase, which also interacts with Migfilin, which has 
shown to protect the process of anoikis (Zhao et al., 2009). 
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Migfilin has multiple roles and different co-localizations in the cell. In the nucleus 
it serves as a transcription co-factor. And in the cell cytoplasm, it interacts with cadherin 
β catenin complex for cell-cell adhesion. And recruitment to focal adhesion is 
accomplished by interacting with Kindlin. 
 
Figure 1.5. Migfilin interacting domains. (Wu, 2005). There are 3 
isoforms of Migfilin in human. Migfilin, Migfilin(s) which lacks the proline 
rich region and FBLP-1 which lacks LIM 3 domain. Four binding partners 
of Migfilin have been identified so far. Mig-2 or Kindlin 2 interacts to 
LIM23 domain. 
ILK. 
Integrin linked Kinase shortened as ILK was first identified as an integrin β1 
binding protein in 1996 (Hannigan et al., 1996). ILK is a 59kDa, comprises of a 
pseudokinase domain, a PH domain and (Fukuda et al., 2009) four ankyrin like repeats.  
Kindlin 2 is required for the localization of ILK to focal adhesions (Montanez et al., 
2006). Interestingly, both ILK and Kindlin 2 were overexpressed at the growing front of 
malignant mesothelioma tumor and weakly expressed at the middle of the tumor. This 
shows that both ILK and Kindlin 2 are important for cell migration (An et al., 2010b). 
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The interaction between ILK and Kindlin has not been investigated at the molecular 
level.  
 
1.5. Aim of the project 
Despite the detailed information on the clinical significance and biological role of 
Kindlin proteins, much is not known about the mechanism of cooperate regulation of 
Talin and Kindlin in integrin activation. Moreover, even less is known about the 
structural aspects of Kindlin proteins and their functions. This thesis focuses on 
investigating the molecular mechanism of Kindlin, predominantly Kindlin 2, and its 
binding partners in regulating Talin induced integrin activation.  
Based on facts from literature, we have proposed a model for integrin activation, 
which is shown in a schematic diagram in figure 1.6. The model suggests that Filamin is 
bound to integrin at the resting or inactive states of integrins. Migfilin is able to bind to 
Filamin and displace Filamin from the integrin β CT. This interaction makes the integrin 
β CT available for potent activation by Talin and Kindlin, a key process of all cell 
adhesive processes. Data from our laboratory have shown that Migfilin displaces Filamin 
from integrin and promote integrin activation (Ithychanda et al., 2009b; Ithychanda et al., 
2009c). However, some of the key aspects of the model are yet to be proved. 
 In vivo studies by Tu and co-workers have shown that Migfilin is recruited to 
focal adhesion sites via Kindlin 2. More specifically, the LIM domains of Migfilin have 
shown to be responsible for this interaction with Kindlin 2 (Tu et al., 2003).  The 
interaction between Kindlin C-ter and integrin has been established through several 
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studies (Ma et al., 2008; Malinin et al., 2010). The binding interface between Kindlin and 
Migfilin is assumed to be between the LIM domains of Migfilin and Kindlin N-ter 
region. But how exactly this binding interaction occurs is not clear. In addition how 
significant this binding interaction is for integrin activation and subsequent cellular 
processes needs to be evaluated and will be addressed in this thesis.  
 
Figure 1.6. A model for the Migfilin/filamin interaction in regulating 
integrin activation and cytoskeleton reassembly. Migfilin is recruited by 
Kindlin-2 (Mig-2) to integrin adhesion sites (Tu et al., 2003). The recruited 
Migfilin promotes the dissociation of inhibitory filamin from integrins and 
facilitates the talin/integrin interaction as well as the anchoring of kindlins 
to integrin beta CTs and strengthens the talin effect in integrin activation. 
Since filamin is a major actin crosslinking protein critical for maintaining 
the actin network, the Migfilin-induced disconnection between integrin and 
filamin may also cause temporal rearrangement of the integrin-actin linkage 
to facilitate the cytoskeleton remodeling. 
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Another interesting aspect of the model is how Kindlin interacts with the integrin 
CT and other proteins to facilitate directly or indirectly in Talin induced integrin 
activation. Talin is a known activator of integrin activation and the mechanism of integrin 
activation and the auto inhibitory mechanisms are well established (Goksoy et al., 2008) 
(Shattil et al., 2010) (Vinogradova et al., 2002; Vinogradova et al., 2004). However, the 
contributory mechanism of Kindlin in Talin induced integrin activation is unclear. It has 
been shown through various functional assays from our collaborators’, that the interaction 
between Kindlin 2 PTB domain and integrin β3 CT has a pronounced effect on integrin 
activation. More specifically phosphorylation of Y759 of integrin CT has a negative effect 
on Kindlin 2 binding (Shi et al., 2007; Ma et al., 2008; Bledzka et al., 2010). Up to date 
there is no structural information on the interaction between Kindlin 2 C-terminal F3 
domain and integrin. We aim to understand the interaction between Kindlin 2 C-ter and 
integrin through structure based analysis and understand its role in the mechanism of 
integrin activation.   
Lack of descriptive information about the structural details of Kindlin 2 in 
literature makes it difficult to evaluate our hypothesis to understand its function. To have 
a better understanding of the protein in a structural point of view, we have obtained a 
model structure of the full length Kindlin 2 protein.  
To evaluate our hypothesis’s we undertook a vigorous structure based investigation 
approach using NMR as our major tool. A structural analysis allowed us to understand 
the molecular mechanism of interaction and pin down the exact binding interfaces.    
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Our aims are as follow: 
1. To solve the structure of Kindlin 2 N-ter. 
2. To understand the functional significance of Kindlin 2 N-ter. 
3. To resolve the structural determinants of Kindlin 2, Talin and Migfilin. 
4. To understand and evaluate the interactions of Kindlin 2 C-ter. 
Overall, both in vivo and in vitro experiments should help us to elucidate the 
mechanism of cooperate regulation of integrin. This work broadens our understanding of 
how Kindlin 2, Talin and Migfilin interactions mediate integrin activation. To date, there 
is a lack of information about the structural details of Kindlin and its interactions in 
particular. These aims will give us a molecular level understanding about the subdomain 
structure and function of Kindlin 2 and will help us to understand the pathogenesis of 
related human diseases.  
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CHAPTER II  
 
TECHNIQUES IN STRUCTURAL BIOLOGY 
 
2.1. Nuclear Magnetic Resonance Spectroscopy 
2.1.1. Overview   
NMR is a branch of spectroscopy where the inherent property of magnetization 
splitting of nuclei is observed by the interaction of radio frequency wave. This 
phenomenon was observed in 1946.  Since then a large number of discoveries in the field 
of NMR have led to applications like macromolecular structure determination, Magnetic 
Resonance Imaging, interaction studies such as molecular dynamics and kinetics. NMR is 
the only technique available which allows performing experiments in all three states of 
matter, solid, gas and liquid. Liquid NMR is the most common of all for small molecules 
like organic compounds, pharmaceuticals and macromolecules such as protein, DNA etc. 
Solid state NMR is becoming popular, to overcome certain drawbacks in liquid NMR. 
NMR on gaseous samples is the least common in the field. 
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NMR is one of the two techniques available to determine three dimensional structures at 
atomic resolution. Macromolecular X-ray crystallography is the other.  Despite the 
occurrence of a huge percentage of protein crystal structures in the protein databank, 
NMR has been the method of choice in understanding the dynamic function of a binding 
interaction (Wuthrich, 1991). The significance of the NMR technique was appreciated by 
winning the Nobel prizes in 2002 - Kurt Wurthrich, 2001- Richard. R. Ernst, 1952 – Felix 
Bloch for their contributions. The discovery of Fourier transformation and the 
development of multi dimensional NMR spectroscopy in the late 1960 were the most 
important turning points in the field of NMR. Advancement from fully-manual to semi-
automated with the improvement/development of various computer software packages 
and the discovery of recombinant protein technology improved the area of 3D biological 
structure determination. Nowadays, NMR is playing an important role in 3D structure 
determination, structural genomics and protein-protein interaction studies. 
The goal of this thesis is to understand the molecular role of Kindlin 2 in integrin 
activation. The structure of Kindlin 2 protein helps us to elucidate the binding 
interactions at an atomic level. Here we have used NMR as the method of choice for 
structure determination of Kindlin 2 F0 subdomain. In addition, we used NMR as our 
primary tool to understand protein-protein interactions. 
 
2.1.2. Protein structure determination 
Protein structure determination is a multiple step process (Wuthrich, 1989a; 
Wuthrich, 1989b). In brief, the first step in the process of protein structure determination 
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is sample preparation, which is followed by data collection, data processing, assignment 
and structure calculation. A very short outline of each step is described below.  
Sample preparation  
A typical NMR sample for structure determination must have an average 
concentration of 1mM protein. With the development of Shigemi NMR tubes the volume 
requirement has significantly reduced from 0.4ml to 0.2ml. Isotope labeling is another 
requirement for protein NMR, which reduces spectrum complexities and eases the 
process of structure determination.  
Proteins comprise of naturally occurring isotopes of 12C, 1H, 14N etc. 1H is a 
magnetically active atom that plays a key role in NMR. Although 12C nuclei is 
magnetically inactive and 14N is less sensitive for detection, their corresponding isotopes, 
13C and 15N, are magnetically active and sensitive for detection (spin half) and can be 
easily incorporated into proteins using isotope labeling methods (Sambrook et al., 1989). 
Isotopic labeling is an essential step in a wide range of applications in NMR (Montelione 
et al., 2000; Shuker et al., 1996). Currently, the most widely used method for labeling 
proteins is recombinant protein expression. A 1H, 13C and 15N triple labeled protein 
sample increases NMR spectral resolution and simplifies subsequent structure 
determination steps.  
 NMR spectra - data collection 
For small proteins with less than 50 amino acids (<10KDa), homonuclear 2D 
experiments such as COSY, TOCSY and NOESY are sufficient for structure 
determination (Wuthrich et al., 1982). However, for larger proteins (>100 amino acids) 
 21 
homonuclear spectra become crowded and heteronuclear multidimensional experiments 
are necessary for better signal resolution and less spectral complexities. 
The most widely used heteronuclear 2D NMR technique is HSQC (heteronuclear 
single quantum coherence). The magnetization is transferred from 1H backbone proton to 
the attached 15N of backbone NH2 group via scalar couplings. Thus each amino acid in 
the protein with N-H group gives a signal in an HSQC spectrum.  
To further simplify and improve resolution of protein spectra for the 
determination of structure, 3D NMR experiments are crucial. A number of triple 
resonance NMR experiments were developed for 15N, 13C and 1H/2H isotope labeled 
proteins.  
Assignment 
The process of cross-connecting resonance signals of NMR spectra to atomic 
nuclei of proteins is termed assignment. The assignment process has two steps. First, the 
backbone assignment of the protein and second the side chain assignment of each amino 
acid of the protein. There are different sets of multidimensional through-bond 
experiments, which transfers magnetization through the peptide bonds and are used for 
the resonance assignment of protein.  
For small proteins the most simple and straightforward method for protein 
backbone assignment is to analyze CBCANH and CBCACONH spectra. An alternative 
method for large proteins with >100 amino acid residues is to find backbone linkages 
through HNCO, HNCACO, HNCA and HNCACO NMR spectra (Muhandiram and Kay). 
Nowadays, computer programs are used for the semi-automatic backbone assignment of 
proteins. MARS, PASA, GANA are well-known among them. The side chain resonances 
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are commonly assigned through HCCH-TOCSY. This experiment couples aliphatic side 
chain protons and 13C resonances through J-coupling constants. Once the resonance 
assignment is complete the next step is restraint generation. 
Restraints 
There are several types of restraints that are used for structure determination: (1) 
Distance restraints are the distance between two atoms; these are obtained from NOESY 
spectra (Jeener et al., 1979; Williamson et al., 1985; Williamson et al., 1985). (2)  
Dihedral angle constraints from J coupling constants and chemical shifts; obtained 
automatically through TALOS program. (3) Residual dipolar couplings. (4) H-bonds and 
disulfide bond restrains.  
In NOESY experiments, the magnetization is transferred through-space between 
nuclei close in proximity via nuclear Ovenhausen effect. The intensity of a peak in a 
NOESY spectrum is related to the distance between the two proton nuclei (Wiliamson et 
al., 1985). Ideally, the intensity of a NOESY cross-peak is directly proportional to 1/r-6 
of the distance between the two atoms. But experimentally this is not always true. 
Various factors affect the NOE signal intensity such as indirect magnetization transfers 
due to spin diffusion.  
TALOS is a program (Cornilescu et al., 1999) that searches a database of high 
resolution protein structures. It relates experimentally measured backbone chemical shifts 
to chemical shifts in already known secondary structures, and correlates that to backbone 
torsion angles. 
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Structure calculation  
The next step is structure calculation. Various software packages are used for 
structure calculation: XPLOR-NIH, CYANA etc. All restraints that were determined 
experimentally are used as an input for calculating an ensemble of 3D structures.  
The quality of NMR structures 
There are several parameters to access the quality of NMR structures. One 
measure is the convergence. A high convergence of the calculated ensemble of 
superimposed structures reflects by the low standard deviation of the coordinates of the 
structures. However, a good convergence does not necessarily represent the accuracy of a 
structure. The Ramachandran plot is another parameter which evaluates validity of the 
backbone torsion angles (Ramachandran et al., 1963). The backbone of a protein should 
have a RMSD (measures the position of each atom coordinate on average throughout all 
the structures) of 0.4º and side chain atoms a RMSD of 1.0º for a structure with high 
precision. A high resolution NMR structure has on average 15-20 NOE distance restraints 
per residue and 3.5 long range distance restraints per residue in the structured regions.  
 
2.1.3. Methods and materials 
We acquired all NMR experiments at 298K under 600, 800 and 900 MHz 
BRUKER AVANCE spectrometers equipped with a cryoprobe. We used NMR-PIPE 
(Delaglio et al., 1995), PIPP (Garrett et al., 1991), NMRDraw and NMR View (Johnson 
and Blevins, 1994) to process out NMR data.  
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NMR sample preparation and data collection for structure calculation 
I prepared a 1mM of 15N and 13C labeled Kindlin 2 1-105 sample for NMR data 
collection and dialyzed the protein against a buffer solution containing 50mM Sodium 
phosphate, 100mM sodium Chloride, 1mM DTT, 0.05% of sodium azide at pH 6.8, with 
a final of 10% (v/v) D2O. HNCA (Kuboniwa et al., 1994), HNCO, HNCACB 
(Muhandiram and Kay), HNCACO, HSQC and CBCACONH spectra were acquired on a 
cryoprobe equipped 600 MHz spectrometer.   
I prepared a 100% D2O sample for 2D-TOCSY experiment, and an isotopically 
unlabeled 1mM Kindlin 2 1-105 sample for the collection of NOESY spectra.  
Protein backbone assignment 
We used PASA protocol for the initial semi-automatic sequential backbone 
assignment (Xu et al., 2006). We analyzed the ambiguous connections manually using 
HNCO - HNCACO and HNCA - HNCACB for the sequential assignment of backbone 
amides.  
Protein side chain assignments 
We used HCC(CO)NH and CC(CO)NH triple resonance spectra for assigning 
hydrogen nuclei and carbon nuclei respectively. In addition, we used HCCH-TOCSY 
experiment and NOSEY experiments to assist in the protein side chain assignment.   
Interaction studies 
For 2D 15N-1H-HSQC (Kay et al., 1992) experiments, 0.05-0.2mM protein 
samples were dialyzed against 50mM Sodium phosphate buffer containing 100mM 
Sodium Chloride at pH 6.8 buffer. I removed DTT from the buffers during interaction 
studies with Migfilin LIM domains but was present for all other experiments. We used 
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the pulse sequences dk-hsqc and fhsqc3gpph for almost all HSQC experiments. We 
collected spectra on a BRUKER AVANCE ICE spectrometer equipped with a cryoprobe.  
 
2.2. Recombinant protein expression and purification 
The requirement of a high concentration of protein is one requirement for NMR. 
A typical NMR sample for structural studies needs around sub molar concentration of 
protein. Such high amount of protein is difficult to purify from native cells i.e. it’s time 
consuming and non economical. Recombinant Protein Expression technologies are 
commonly used to obtain a high concentration of pure protein. 
Fusion proteins are used for the ease of purification. Histidine tag, Glutathione 
transferase Tag and Maltose binding protein Tag are commonly used fusion proteins 
which ease the isolation of target protein from crude lysate. 
 
2.2.1. Protein expression optimization 
Theoretically, recombinant protein expression techniques have a potential to 
express high levels of proteins. However, this is not observed in vivo. There are a 
limitless number of factors that suppress, limit, and prevent the expression of 
recombinant proteins in E. coli bacteria. In addition, the expressed protein can encounter 
endless factors which prevent it from being able to isolate. The stability of the protein is 
one important factor which reduces the yield of the protein. The instability could be due 
to many reasons such as prone for proteolytic cleavages, inherent instability of the protein 
etc. Precipitation of the protein is another factor which reduces the final yield of the 
protein. Protein aggregation is a common incident in recombinant protein expression 
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systems. Aggregation can be explained as a process of oligomerization of protein. This 
could be lower oligomer formation such as dimers, trimer, tetramer or higher oligomers. 
Lower oligomers are manageable for functional analysis.  Oligomerization can be 
nonspecific by forming aggregates. Most often unfolded proteins and very hydrophobic 
proteins have a tendency to form massive aggregates. In fact, there are many other 
reasons which abolish the expression of a protein which will not be discussed in detail 
here.  
 
2.2.2. Materials and methods 
Kindlin 2 constructs.  
We used the cDNA of full length human Kindlin 2 as a template for subcloning. I 
chose the boundaries for each protein according to secondary structure prediction of the 
full length Kindlin 2 obtained from the PSIPRED web server. In later subclonings, I used 
the 3D model structure of full length Kindlin 2 to assist in choosing the boundaries of the 
protein. For Kindlin 2 N terminal sequences, I used EcoRI and XhoI or XbaI restriction 
enzyme sites to clone the insert into the cloning vector. For C terminal sequences, I used 
either BamHI and NotI, or BamHI and XbaI restriction enzyme sites for cloning 
purposes. The cDNA of the C-terminal FERM regions have multiple restriction enzyme 
sites within their sequences. I cloned the cDNA of each insert in to cloning vectors shown 
in Table 2.1: PGEX-4T-1 (Pharmacia) or pGEX-4T-1 derived parallel GST 1 (pGST-1) 
for GST fusion proteins, pHis-1 or pET30a or pET15b for His-tagged fusion proteins and 
pMAL-c2x or pMBP-1 for MBP fusion proteins. I cloned some sequences into pMAL-
c2x-His tag engineered cloning vector which was kindly provided from Dr. Jun Yang. I 
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transformed the cloned protein expression vectors into DH5α bacterial host strains and 
plated on appropriate antibiotic resistant plates. The bacterial colonies were subjected to 
colony PCR (Sambrook) to screen for positive colonies bearing our cloned insert. We 
used a Miniprep or Midiprep preparation (Promega) to isolate DNA plasmids from 
bacterial cells of our cloned protein expression vectors. Finally, I used the support of the 
CCF sequencing core to verify the accuracy of the cloned sequences. I transformed  
KINDLIN-2  FUSION  BACTERIAL   
BOUNDARIES   TAG    HOST STRAIN  
1-134    HIS  Rosetta 2  
     GST    Rosetta 2  
1-154    HIS  Rosetta 2  
1-158    HIS  Rosetta 2  
1-218    GST     Rosetta 2  
11-177   GST     Rosetta 2  
11-143   HIS    Rosetta 2  
     GST     Rosetta 2  
GST  BL21(DE3) gold  
MBP   Rosetta 2  
MBP    BL21 (DE3) RIP 
MBP-HIS Rosetta 2 
1-105   GST    BL21 (DE3) pLys  
   HIS    BL21 (DE3) pLys 
GST    Rosetta 2 
GST    Rosetta 2 
GST   Rosetta 2 
95-276   GST   Rosetta 2 
95-168    GST   Rosetta 2 
95-268   GST  Rosetta 2 
95-154   GST  Rosetta 2 
155-268   GST  Rosetta 2 
  
Table 2.1. Kindlin-2 N’ term recombinant proteins. 
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KINDLIN-2 FUSION BACTERIAL   
BOUNDARIES   TAG    HOST STRAIN  
565-658  GST  BL21 (DE3)  
MBP-HIS BL21 (DE3)   
 BL21 (DE3) 
    Rosetta  (DE3)       
Rosetta 2 (DE3)  
567-662  HIS  Rosetta 2  
  GST  Rosetta 2  
567-665        HIS    Rosetta 2 
  GST  BL21 (DE3) pLys 
    Rosetta 2 
567-680  GST  BL21 (DE3) pLys 
Rosetta 2 
485-665  GST  BL21 (DE3) pLys 
    Rosetta 2 
395-567  GST  Rosetta 2 
459-567  GST  Rosetta 2 
477-567  GST  Rosetta 2  
 
Table 2.2. Mig-2 C’ term recombinant proteins. 
sequence verified protein expression vectors into one or more protein expression E.coli 
bacterial strains, BL21 (DE3), BL21 (DE3) pLys, BL21 (DE3) pLys Gold, BL21 (DE3) 
RIP (Stratagene)  and Rosetta 2. 
Migflin constructs. 
cDNA of human Migfilin(s) was kindly provided from our collaborators. I used 
PCR to amplify the cDNA of the C terminal LIM domains, LIM123 (residues 172-367 
and 172-373), LIM23 (residues 241-367 and 241-373), LIM2 (residues 241-304) and 
LIM3 (residues 298-367) of human Migfilin. We used a high fidelity DNA polymerase, 
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Pfu Ultra DNA polymerase (Invitrogen), for PCR reactions. I used parallel GST-1 and 
parallel His-1 vectors for most of the cloning work. All parallel vectors were kindly 
provided by Dr. Saurav Misra. I transformed sequence verified protein expression vectors 
into Rosetta 2 (DE3) for subsequent protein expression.  
Talin constructs. 
Full length human Talin 1 encoding cDNA sequence was provided from Dr. Ma 
Yang-Qing. I cloned Talin head domain and its subdomains into parallel His-1 vectors. I 
ordered all primers from Integrated DNA technologies, and used PCR with primers 
consisting EcoRI and XhoI restriction sites to amplify cDNA of Talin F0 domain residues 
1-86, Talin F0F1 residues 1-206, Talin F1 residues 86-206, Talin F2F3 residues 206-429 
and Talin H (F0F1F2F3 residues 1-429). I transformed the sequence verified constructs 
into BL21 (DE3) for protein expression.  
Optimization.  
All constructs were optimized for their expression and protein solubility at 
varying temperatures. I used induction temperatures ranging from 15ºC, 20ºC, 25ºC and 
37ºC for a temperature dependant optimization, IPTG concentrations between 0.2mM 
and 1mM for optimization for protein expression, and time of induction from 4hrs, 16hrs, 
18hrs and 24hrs. I employed this approach for almost all constructs individually. 
We implemented an intense optimization approach for Kindlin 2 11-143 
construct. For this construct besides the aforementioned optimization strategy I 
performed the following strategies to increase the final yield of the protein: protein re-
folding using decreasing percentage of urea and Foldt Screen (Hampton Research), auto-
induction medium for protein expression, chaperone assisted folding (Takara) by co-
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expression of chaperones, applying a cold shock and heat shock for bacterial cells, codon 
optimization for bacterial expression, varying of vector i.e. fusion tags (GST, HIS, MBP, 
MBP-HIS, NUS-HIS), surface cysteine mutation, and use of a variety of detergents.  
Protein expression and purification. 
After optimization, we expressed the fusion proteins in LB (Lennox L Broth) 
culture media or TB (Terrific Broth) culture media (RPI co-operation) and harvested at 
3500rpm for 15min (Sorvall). We suspended the cell pellets in the lysis buffer which was 
incorporated with 10mg of lysozyme per 50ml lysis buffer, EDTA free protease inhibitor 
cocktail (Biocompare), deoxyribonuclease and Magnesium ions. We froze the mixture in 
liquid nitrogen and incubated the frozen cell pellets at 4ºC with slow rotation overnight 
for cell lysis. The cell lysis procedure for proteins that tend to be unstable (Kindlin 2 168-
268) was different. Those cells were immediately ruptured after harvesting by mechanical 
methods using a French-press or short pulses of sonication. I used phosphate buffered 
saline (PBS) as the lysis buffer for GST fusion proteins, a 20mM Tris buffer with 0.2mM 
NaCl, 1mM EDTA, 10µM beta mercapthoethanol buffer solution as the lysis buffer for 
MBP tagged protein and 300 mM phosphate buffer with 500 mM NaCl, pH 8.0 
containing 10mM imidazole for His fusion proteins. 
We purified the fusion protein using affinity chromatography with Nickel-NTA 
resin (Qiagen), Glutathione sepharose 4b resin (GE healthcare), and amylose resin (NEB) 
for each HIS, GST and MBP fusion protein purifications respectively. We cleaved the 
fusion tag with a suitable protease which is TEV protease for proteins derived from 
parallel cloning vectors, Thrombin protease (Sigma) for pGEX derived cloning vectors 
and pET15b and Faxtor Xa protease (Novagen) for pET30a cloning vectors in 
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appropriate buffers and cleavage conditions. We further purified the protein using size 
exclusion chromatography, either Superdex 75 or Superdex 200 matrix (Amersham 
Bioscience) depending on the size of the protein. 
Isotope labeling 
Isotopically labeled proteins are required for 3D NMR experiments for structure 
determination. We used 15NH4Cl as the 15N source and 13C glucose as the 13C source in 
culture medium to obtain 15N and / or 13C enriched proteins.  
During isotopic labeling of Zinc finger proteins, I added 1ml of 0.1M ZnCl2 per 1L to the 
media just before induction of protein. We routinely performed overnight induction either 
at room temperature or at 20ºC. For Migfilin LIM domains, the best optimization 
condition in LB is induction overnight at 15ºC, and for isotope labeled LIM domains the 
best induction temperature was 25ºC. 
Mutagenesis 
Kindlin 2 11-143 protein has two Cysteines. I introduced a point mutation at 
C12S of Kindlin2 11-143 construct using the Quick Change Site Directed Mutagenesis 
Kit (Stratagene). 
I prepared a sequence deletion mutation for the integrin activation assay 
performed by Dr. Ma. I deleted residues ranging from 11-143 from the full length Kindlin 
2 sequence using Quick Change Site Directed Mutagenesis Kit (Stratagene). 
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2.3. Macromolecular X-ray crystallography 
Besides NMR, macromolecular X-ray crystallography is the widely used 
technique for 3D protein structure determination. More than 80% of the protein structures 
deposited in the protein data bank (PDB) are derived from X-ray crystallography. The 
basic principle in X-ray crystallography relies on the diffraction of the X-ray wave by the 
electron cloud of the protein. Structure determination by X-ray crystallography involves 
multiple steps. The major requirement for X-ray structure determination is the 
requirement of a ‘solid’ protein crystal. The crystal should be >10A° in length in all 3 
dimensions, with uniform composition and lack of physical imperfections. The crystal is 
placed in an X-ray beam and its diffraction patterns or reflections at continual angles 
throughout the crystals z axis are recorded. All recorded reflections are processed via 
mathematical formulations computationally and subsequent refinement produces a 3 
dimensional protein structure.  
Structure determination by X-ray Crystallography takes less time and is automatic 
compared to NMR that takes a longer time with more manual involvement. NMR protein 
structure determination is limited to 30-40 kDa protein whereas in X-ray Crystallography 
there is no size limitation. However, X-ray crystallographic approaches always require a 
crystal or multi crystal complex of the protein, which limits its usage as some proteins are 
difficult to crystallize or not able to crystallize at all. Most importantly, X-ray 
crystallography will not show the dynamic effects of an interaction process, rather it 
gives a snapshot of an end result of an interaction. Therefore, besides structure 
determination, NMR plays a crucial role in the understanding of the dynamic function of 
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a binding interaction process. (Wuthrich, 1991). Besides NMR, we used X-ray 
crystallography as an alternative step for protein structure determination. 
 
2.3.1. Materials and methods 
Kindlin 2 11-143 and 1-105 
We expressed Kindlin 2 11-143 and 1-105 protein expression constructs as a GST 
fusion proteins in E. coli BL21 (DE3) pLys cell line. A cold shock was applied to cell 
cultures by incubating the cultures in an ice-water bath for 30 min, followed by induction 
with 0.5mM IPTG at room temperature 298K for 16hrs. The purified protein was 
concentrated to 1mM (15mg/ml) and dialyzed overnight into crystallization buffer 
containing 20mM Tris-HCl, 50mM NaCl, pH 7.0, and 1mM DTT. We transformed 
Kindlin 2 11-143 construct into B834, a Methionine auxotroph bacterial strain of E. coli, 
to obtain Selenomethionine labeled protein.  
Crystallization 
We used the hanging drop vapor diffusion method for growing crystals 
(McPherson et al., 1995).  We used Commercially available crystal screening kits for 
screening around >600 different crystal conditions, Crystal Screen I & II, Salt Rx, Index, 
Wizard I & II, Nextal Classic L suite, Protein Complex, Additive screen (Hampton 
Research screening kits, Qiagen screening kits). Each crystal drop had a total volume of 
2µl comprising of 1 µl of 15mg/ml protein and 1µl of crystallization condition. The well 
volume was 150µl. I optimized crystallization buffer for its pH, buffer concentration, 
additive/precipitant concentration and salt concentration. 
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X-Ray data collection and analysis 
We flash froze crystals after soaking in a gradient of cryoprotectant solutions. The 
gradient soaking follows as: the crystal was first transferred from the crystallization 
buffer to a 10% Ethylene glycol containing crystallization buffer, from there to a 5% 
glycerol and 15% Ethylene glycol mixture containing crystallization buffer and  finally 
into a  5% glycerol and 20% Ethylene glycol containing crystallization buffer solution. 
We acquired diffraction data using Case Pharmacology X-ray facility and at the Advance 
Photon Source at Argonne National Laboratory IL. At Case X-ray facility, the crystal to 
detector distance was 80mm. We collected diffraction data at 0.5º oscillation angle 
throughout 180º and exposed each frame for 30 sec. Finally, we analyzed our acquired 
diffraction data using HKL2000 software.  
 
2.4. Isothermal Titration Calorimetry (ITC) 
2.4.1. Overview 
ITC has become an invaluable tool in biological sciences and pharmaceutical 
industry. We used ITC to understand the energetics of our binding interactions. ITC 
measures the associated heat change of an interaction process at constant pressure and is 
able to obtain all thermodynamic parameters such as ∆G, ∆H, ∆S, Ka / Kd and 
stoicheometry, in one single experiment giving a complete thermodynamic profile of the 
binding interaction. ITC can be used with any buffer, at any pH, any solution whether 
clear or turbid. Despites its significant advantages, ITC has several drawbacks. One main 
consideration is the amount of sample material required for one single experiment. In 
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addition, ITC can only measure a heat energy difference of a particular reaction. But 
there are reactions which are entropically driven and are not able to detect by ITC.  
2.4.2. Design of an ITC experiment 
Strong binding < 0.1nM and weak binding > 10nM interactions cannot be 
evaluated for its precision and accuracy by ITC. The value of c (c= Ka[M]n) should be 
between 1-1000 to perform an accurate experiment with a sigmoidal curve.  
When designing an experiment, the ligand and macromolecule, should be in the 
exactly same buffer. Control experiments should be performed to evaluate the heat of 
dilution of the macromolecule-protein, heat of dilution of the ligand and heat of mixing. 
The concentrations of the protein and ligands have to be accurately measured as it 
directly correlates with the final results. The choice of buffer is important as certain 
buffers containing large molecules (Tris buffer) have a large heat of dilution signal in 
which the actual binding signal can be masked. To achieve better sensitivity the choice of 
buffer should always be a small ion buffer such as phosphate. Reducing agents like DTT 
may cause unstable and noisy baselines which may affect the end-results. Furthermore, 
degassing buffers is a very important step as the entrapment of tiny air-bubbles in the 
system can contribute to a noisy base-line. Data analysis is performed using ORIGIN 7.0 
software which was provided by Microcal Corporation.  
 
2.4.3. Materials and methods 
Talin and lipid interaction 
We performed a series of ITC titrations between Talin subdomains and PIP2 
lipids. I dialyzed Talin proteins of 50µM concentrations overnight into buffer containing 
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50mM Sodium phosphate, 150mM NaCl, pH 6.8. The buffers were filtered using a 0.2µ 
filter and degassed thoroughly. I suspended the lipids of PIP2 C4 and PIP2 C6 (Echelon) 
in the buffer being prepared to a final of 1mM. All experiments were carried out at 298K 
with a stirring speed of 300rpm. I performed titrations of a total of 30 injections with an 
injection volume of 7.5µl and 4 min spacing time between each injection. Finally, I 
collected data on a VP-ITC instrument from Microcal Inc. and analyzed results using 
Origin 7.0 software.  
Talin and Migfilin interaction 
I used a 50µM concentration of Talin F0 for the initial ITC titration experiment.  I 
dialyzed all protein samples, ligand and macromolecule, overnight into the same buffer of 
50mM Sodium phosphate, 100mM NaCl, pH 6.8. The titration was performed on a 
ITC200 ultrasensitive micro-calorimeter instrument (Microcal). I performed the titration 
between Talin F0 and Migfilin LIM23 in 2µl aliquots of 30 injections. I used a 2mM of 
LIM23 as the syringe protein concentration, and analyzed the results using Origin 7.0 
software from Microcal.    
 
2.5. Surface Plasmon Resonance Spectroscopy (SPR) 
Surface Plasmon Resonance Spectroscopy (SPR) is the most widely used 
technique to study and characterize an interaction between two molecules. We used SPR 
to understand the binding affinity of a particular interaction, the need of a small sample 
size and versatility of the instrumentation and usage. However, the error associated of a 
weak interaction and using small molecules is high.  
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The basic principle underlying SPR was discovered in 1950s. The phenomenon of 
the emission of surface Plasmon radiation at the total internal reflection angle of a light 
beam at two density mediums (with one coated with a metal layer) is the basic principle 
in SPR. However, the first instrument was developed in the late 1980’s. The intensity of 
the emitted surface Plasmon wave is proportional to many factors such as the type of 
metal, the thickness of the metal layer and the density of the medium. The mass density 
of the medium is utilized in biosensor chip development by immobilizing a wide variety 
of ligands.  
 
2.5.1. Materials and methods 
We performed all experiments on a BIACORE 3000 (Amersham Pharmacia) 
instrument at CCF-LRI Biotechnology core. We used CM5 sensor chips (Biacore) for 
most SPR experiments. EDC, NHS and ethanolamine were prepared from the amine 
coupling kit (Biacore).  I filtered and degassed all buffers though a 0.2µ filter and also 
used research grade buffers from Biacore.  
Kindlin 2 and Migfilin interaction 
We immobilized Kindlin 2 11-143, full length Kindlin 2 and Kindlin 2 1-105 on 
CM5 sensor chip flow cells using amine coupling chemistry. Densities reached to 1000 
RU during immobilization.  We exchanged all ligands to exact buffer as the running 
buffer. Ligands used for interaction studies are: Migfilin LIM23, LIM1, LIM2, LIM3, 
LIM123 and LIM12. Data collecting was achieved using Biacore control 3000 software 
and data analysis was done using BIAevaluation software version 4.0. All experiments 
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were done at 25ºC unless otherwise noted. The running buffer used was 50mM Sodium 
phosphate, 100mM NaCl, pH 7.0. 
Talin and Migfilin interaction 
We immobilized Talin F0 and Talin F0F1 proteins on CM5 sensor chip the same 
way described above. HBS buffer from Biacore was used as the running buffer. Migfilin 
LIM23 and LIM1 proteins were the interacting partners for the experiment.  
Kindlin 2 PH domain and PIP3 interaction 
I immobilized PIP3 lipids on a L1 sensor chip the same way as described above. 
HBS buffer from Biacore was used as the running buffer. Kindlin 2 PH domain (provided 
by Dr. K. Fukuda) was used as the interacting partners for the experiment.  
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CHAPTER III  
 
KINDLIN 2 N TERMINAL STRUCTURE  
 
3.1. Introduction 
Kindlin family proteins play an important role in the human body. The health 
related importance of Kindlin 2 was described earlier in chapter 1. Its role in 
cardiogenesis as well as in maintaining the homeostasis of adult heart function makes 
Kindlin 2 unique among the Kindlin family proteins (Dowling et al., 2008; Hatcher and 
Basson, 2008; Orlic et al., 2001). Lack of adequate structural information of Kindlin 
family proteins makes us difficult to understand the molecular mechanism of its function. 
Kindlin 2 is a relatively novel protein and structural details about Kindlin 2 are hardly 
known. However, the F0 domain of Kindlin 1 protein was recently resolved (Goult, B.T. 
et al., 2009). This chapter specifically discusses the structural details of Kindlin 2 N- 
terminal F0 domain.  
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3.2. Expression of Kindlin-2 N terminal domains 
The requirement of a sub-molar concentration of protein is one of the crucial 
factors in protein structure determination. In addition, the stability of the protein at room 
temperature for two weeks is another major requirement. Proteins that fall into both 
categories are not abundant in vivo. Kindlin 2 is such a cumbersome protein which 
required a trial-and-error approach and a subsequent optimization strategy for expression, 
yield, solubility and stability of the expressed domains. Lack of information in literature 
about the expression conditions of Kindlin variants made us to put an extra effort and 
time on getting the protein for structural studies. Our approach was as follows: 
1. Choosing boundaries and cloning according to secondary structure prediction and 
tertiary model structure prediction of the protein. 
2. Checking the instability index, occurrence of rare codons etc of the protein. 
3. Optimization for expression  
4. Optimization for yield  
5. Optimization for protein solubility 
Aggregated proteins  
Precipitation of the protein 
Stability of the protein 
6. Back to 1 if none of the approaches succeeded.  
Selection of proper boundaries for a protein is the most important step that affects 
the final yield and stability of the protein. I selected the boundaries according to the 
predicted secondary structure of the protein of interest. In here I chose the boundary so 
that it falls into a coiled region of high probability (see Appendix 1).  
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Multiple constructs engineered for Kindlin 2 N-terminal and their expression 
conditions are shown in table 3.1. Most constructs were challenging in terms of obtaining 
the encoded protein in soluble and stable conformation. I carried out an extensive 
optimization approach for each construct. Kindlin 2 11-143 was the initial construct 
which resulted a soluble protein but yielded less than 1mg per Liter of LB culture. I have 
described multiple optimization strategies below which I used to improve the yield of 
Kindlin 2 11-143 protein. 
A major fraction of the protein accumulated in inclusion bodies. I performed a 
protein refolding approach from inclusion bodies for Kindlin 2 11-143 protein. Among 
the available methods, we chose refolding via a decreasing percentage of urea 
concentrations. I compared the 1H-15N HSQC spectra of the native and refolded 15N 
labeled protein. The spectra were completely different implying that refolding failed for 
Kindlin 2 11-143 construct. 
There will be always a controversy arisen when a human protein is expressed in a 
bacterial expression system. Compared to the easiness of handling, low turn-around time 
and recombinant protein expression, bacterial expression systems are always preferred 
against eukaryotic expression systems. To avoid or reduce the conflict of proper folding 
of the protein we used a chaperone co-expression to assist protein folding. I transformed 
different types of chaperone encoding plasmids into the bacterial strains containing our 
expression constructs (Takara). A significant increase in the yield of soluble protein 
could not be observed for Kindlin 2 11-143 protein.  
The codon usage in bacteria is somewhat different from that of Eukaryotic cells. 
The relative frequency that certain human codons are used in bacteria is different as well. 
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For example a human CCC codon for proline has a 0.4% average frequency been used 
per 100 codons compared to other proline encoding codons CCU – O.7%, CCA – 0.8%, 
CCG – 2.4%. As a result there will be a pause during translation as the ribosome has to 
‘wait’ until it gets the CCC tRNA. If the occurrence of rare codons is high moreover 
consecutive, the ribosome may stop translating the protein resulting in a truncated protein 
or may allocate a wrong codon. To prevent such incidents there are bacterial expression 
systems being introduced which increase the pool of rare codon tRNAs within the 
bacteria. E.g. Rosetta, Rosetta2, RIPL etc. Kindlin 2 11-143 has several rare codons. The 
expression of the construct in Rosetta 2 bacterial cells did not increase the solubility of 
the protein (Burgress-Brown et al., 2008, Pro. Exp. Purifi.). 
Another addition for this approach was to synthesize the DNA sequence after 
codon optimization. In here the whole DNA sequence of Kindlin 2 11-143 was 
synthesized selecting or changing rare codons for more abundant codons in bacteria. I 
cloned the cDNA or minigene (IDT, Integrated DNA Technology) into a suitable vector 
and analyzed its expression. Results did not show a significant improvement of soluble 
protein.  
 
Table 3.1. Summary of Kindlin 2 N-terminal constructs.  
 
MIG-2  FUSION                   BACTERIAL  PROTEIN            PROTEIN         GEL 
BOUNDARIES                 TAG   HOST STRAIN EXPRESSION     SOLUBILTY     FILTRATION 
1-134   HIS  Rosetta 2 (DE3)     +             insoluble 
   GST         +             insoluble 
1-154   HIS    Rosetta 2 (DE3)     +                        partly soluble    Aggregate  
1-158   HIS    Rosetta 2 (DE3)     +              insoluble 
1-218   GST      Rosetta 2 (DE3)     +                        insoluble 
11-177  GST     Rosetta 2 (DE3)     +             partly soluble 
11-143  HIS   Rosetta 2 (DE3)      +                        insoluble 
  GST      Rosetta 2 (DE3)     ++             soluble        monomer 
  GST    BL21(DE3) pLys              ++             soluble       monomer 
  MBP    Rosetta 2 (DE3)     +                        soluble       monomer 
  MBP   BL21 (DE3) RIP     +                        soluble        monomer  
             1-105                     GST                              BL21(DE3) pLys              +++             soluble        monomer 
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There are endless possibilities to argue to what may be the cause for poor 
expression and insolubility and what can be done next. However, two major approaches 
were selected and used in this study. First is to subclone a certain region of interest of the 
protein cDNA and optimize extensively for its expression, solubility etc. for a soluble 
monomeric /oligomeric stable protein. Second is to subclone a large number of constructs 
simultaneously varying the boundaries of the protein and check their expression and 
solubility.  Having attempted both strategies, it is quite evident, that the time spent for 
optimizing a protein of a particular construct for endless possibilities is way more time 
consuming and not cost-effective than varying the boundaries of the protein.   
 
3.3. The structure of Kindlin 2 N-terminal 
To understand the role of Kindlin-2 N-terminal in integrin activation, it is 
essential to know the molecular level details about the protein. In order to obtain the 
structure in an atomic level resolution of Kindlin 2 N-terminal, we used a two part 
approach, NMR and X-ray crystallography for potential structure determination of the 
protein. The techniques were described in Chapter II.  
 
3.3.1. Crystallographic approach for Kindlin 2 11-143 
We performed crystallization trials for both Kindlin 2 1-105 and 11-143 proteins. 
Despite the vast yield difference between the two constructs, <1mg/L of LB culture 
media for K2 11-143 and >10mg/L of LB culture media for K2 1-105, we were able to 
obtain sufficient protein for initial crystallization setup. A single crystal was obtained for 
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Kindlin 2 11-143 protein but Kindlin 2 1-105 protein showed no signs of crystallization 
hits so far. Several images of the crystals in different crystallization conditions are shown 
in figure 3.1. The Kindlin 2 full length model structure (Fig 3.10.) shows that there is 
long floppy overhang at the C-terminus from residues 95 to 105 which might have 
prevented tight crystal packing i.e. crystallization. According to the NMR structure of 
Kindlin 2 1-105 (next sub-chapter) the N-terminal 1-12 residues show a very dynamic 
behavior. This may be another reason to prevent crystallization of Kindlin 1-105 protein. 
In contrast, in Kindlin 2 11-143 construct, residues 95 to 143 forms an anti parallel beta 
sheet and a small helix at the C- ter which might have helped in better crystal packing 
and promoted protein crystallization. The model structure was not present at the time of 
choosing domain boundaries for cloning. Having the model structure currently, a much 
better construct would be residues 12-95 or 20-95, which reflects the core region of the 
Kindlin 2 F0 domain. 
We obtained multiple crystallization conditions for Kindlin 2 11-143 protein from 
the initial trial. These are: 
1.  1.4M sodium potassium phosphate, pH 8.2. 
2.  0.1M Tris, pH 8.5, 1.2M sodium potassium tartrate tetrahydrate. 
3.  0.1M Tris , pH 8.5, 0.7M tri-sodium citrate dehydrate  
All conditions where crystallization has occurred had a pH higher than 8.0. Thus Kindlin 
2 11-143 protein crystallization is pH sensitive. We performed optimization around the 
crystallization condition for pH, salt concentration, temperature and buffer concentration. 
The best crystallization condition was 1.6M sodium potassium phosphate at pH 8.2. 
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Figure 3.1. Protein crystal images of Kindlin 2 11-143. (a), (b) and (d) 
grown in 1.4 M sodium potassium phosphates, pH 8.2. (c) protein crystal 
was grown from 0.1M Tris, pH 8.5, 1.2M sodium potassium tartrate 
tetrahydrate. And crystal (e) in 0.1M Tris, pH 8.5, 0.7M tri-sodium citrate 
dehydrate. 
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Further optimization using the additive screen kit for the optimized condition revealed a 
0.1mM of spermidine as the additive constituent. Crystal cryoprotection was achieved 
through a sequential gradient of quick soaks explained in the experimental section of 
chapter 2.3. 
 
Figure 3.2. Diffraction pattern of Kindlin 2 11-143 protein crystal. The 
diffraction patterns on other oscillation angles show severe overlap. The 
crystal is diffracting to 3.0 angstrom resolution, but the 3D structure could 
not be resolved due to severe spectral overlap.   
 
An image of the diffraction pattern of Kindlin 2 11-143 protein crystal is shown in 
figure 3.2. We collected images at 0.5º oscillation angles. A severe overlap was seen 
among most consecutive images. We analyzed the data by HKL2000 software and the 
initial analysis revealed that the crystals diffracted to 2.9 Å resolutions with a space 
group of p21212. We were not successful in the structure determination process due to 
severe overlap of data points. Data analysis from both in-house x-rays and synchrotron 
light source failed due to severe peak overlap of reflections.  
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A future approach would be 0.25º oscillation angle image collection with an 
increase in detector distance. This may expand the peak positioning on the film and may 
prevent the peak overlap. However, due to the very low yield of the protein and 
difficulties in reproducibility, crystallization setup for Kindlin 2 11-143 was not 
convenient.   
 
3.3.2. NMR structure of Kindlin2 N-terminal 1-105 
Kindlin 2 1-105 protein is stable even for weeks at room temperature. I was able 
to concentrate the protein up to 2mM without any signs of precipitation. We used a one 
milli-molar of 15N and 13C doubly labeled sample for structure determination. The 15N-1H 
HSQC spectrum shows excellent chemical shift dispersion with uniform signal intensities 
suitable for detailed NMR studies.  
We selected peaks prior resonance assignment, using NMRview software. We 
first selected peaks of the HSQC spectrum, followed by selecting peaks in triple 
resonance spectra HNCACB and HNCACO. Residues 8 and 68 are overlapping in the 
HSQC spectrum. Another cluster of overlapping residues in HSQC spectrum was 
observed for residues 25, 42 and 66. HNCACB, HNCA and CBCACONH were 
comparatively analyzed for confirmative peak picking in HNCACB spectrum.  Similarly 
HNCACO and HNCO spectra were comparatively analyzed for peak picking in 
HNCACO spectrum. There were difficulties in 100% resonance assignment of HNCACB 
and HNCACO spectra due to overlap of resonances but more than 95% residues were 
assigned. 
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Figure 3.3. 1H-15N HSQC spectrum of Kindlin 2 1-105. The peaks are 
labeled with the corresponding assignment of Kindlin 2 1-105 residues 
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Backbone assignment We used PASA, a software for automatic backbone 
assignment, for backbone assignment (Xu et al., 2006). The chemical shift tables of 
HSQC, HNCACB and HNCACO spectra were used as the input for PASA. We 
completed all ambiguous assignments manually. 88% of the backbone assignment was 
completed (99/112 residues). There are 9 missing peaks: 4 proline residues and residues 
33, 60, 61, 62, 75 which were unable to assign. The assigned HSQC spectrum is shown in 
figure 3.3.  
We calculated the secondary structure of the protein from the C α and C β 
chemical shifts obtained from assigned spectra listed above. The secondary structure 
prediction shows that the protein comprises of a combination of helices and beta sheets. 
The prediction is shown in figure 3.4. An extended helix is observed between residues 
46-58 and a short helix is predicted from the chemical shift indices between residues 85-
89. Beta strands are predicted between residues 24-30, 36-43, 67-73 and 96-100. 
Side chain assignment was not 100% complete. We were able to assign 
approximately 85% of the peaks from both HC(CO)NH and C(CO)NH spectra. Most of 
the peaks were missing and some show severe overlap. A stretch of alternative long side 
chain amino acids leucines and arginines showed missing and overlapping spin systems.  
HCCH-TOCSY spectra were helpful in assisting in side chain assignment of the protein.    
The 3D structure We calculated the 3D structure as described in section 2.1.3. 
The N-ter Kindlin 2 1-105 structure has an ubiquitin-like beta-grasp fold, similar to 
Kindlin 1 structure.  A 12 residues long alpha helix (residues 48-59) is partly surrounded 
by 5 beta sheets of variable lengths. The solution structure is shown in Figure 3.5 and was 
calculated from a total of 1304 restraints. The table of structural statistics for the solution 
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structure is shown in table 3.2. The structured core represents residues 16-93 
(corresponding to residues 23-100 in our structure) has a convergence of 0.4Å. 
 
Figure 3.4. Secondary structure predictions of Kindlin 2 1-105.Chemical 
shift indices correspond to 13Cα and 13Cβ spin resonances of each residue.  
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The N-terminal 1-18 residues of Kindlin 2 1-105 structure shows a helical feature 
spanning residues 6-12 (13-19res in our construct) which we defined by a distinct set of 
NOEs. A beta hairpin is seen within residues 25-42, with β1 from residue 25-31 and β2 
from residues 36-42. Hydrogen bonds were observed between 25-42, 27-40, 29-38 and 
31-36 residues. The turn is defined by 4 residues in which residue Asp 33 is a missing 
spin system. The first helix, α1 is 12 residues in length (res 48-59). Residues 60-62 are 
missing spin systems. The loop from residue 59 to 69 is less defined due to the missing 
stretch of spin systems. Residues 69 to 71 and 77-79 form short beta strands β3 and β4 
respectively.  The fifth beta strand β5, defined by residues 98-100, runs in-between β1 
and β3 with hydrogen bond contacts to both β1 and β3 strands. These strands form a beta 
sheet which covers the hydrophobic side chains of the α1 helix.   
The Ramachandran plot is shown in figure 3.6, which is a sum of 20 low energy 
structures out of 100 structures. 96.4% of residues between 8-101 residues of Kindlin 2 
F0 domain structure belong into the category of allowed region in the Ramachandran 
plot.  The missing spin systems, residues 33 and 60 on the plot are violated among all 20 
calculated low energy structures in the Ramachandran plot. Structural statistics for the 
low energy 20 structures are shown in table 3.2. The overlay of the 100 lowest energy 
structures is shown in figure 3.7. This figure show high convergence of the structures 
between residues 23-100. However the N-terminal tail residues 8-23 display a dynamic 
behavior.  
Overall, Kindlin 2 F0 domain structure is in excellent agreement within the 
quality parameters for NMR solution structure calculation.  
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Figure 3.5. A ribbon diagram of the structure of Kindlin 2 1-105. The α 
helices are depicted in cyan color and the beta strands in magenta. The 
structure shows 2 distinct helices spanning across residues 48-59 and 86-89. 
A helix like feature is apparent in the N-terminus across residues 15-19. 
Five beta strands with varying length partially covers α1 helix. 
 
 
 
 
 
90º 
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 parameters 
NOE distance restraints  
          All   1304 
          Sequential, │i-j│=1 436 
          Medium range,  1<│i-j│<6 222 
          Long range, │i-j│>= 6 295 
Intraresidue 445 
RMSD from idealized covalent geometry  
          Bonds (Å) 0.0057 +/- 0.0001
Angles (deg) 0.6873 +/- 0.0181
Impropers (deg) 0.5258 +/- 0.0124
Total energy (kcal/mol) 811.28 
Ramachandran plot  
Most favored region (%) 69% 
Additionally and generously allowed region (%) 31% 
Disallowed region (%) 0% 
Average RMSD residues 8-100  
Backbone atoms (Å) 1.745 +/- 0.470 
Heavy atoms  (Å)  2.087 +/- 0.418 
Average RMSD residues 23-100  
Backbone atoms (Å) 0.425 +/- 0.105 
Heavy atoms  (Å) 1.002 +/- 0.125 
 
Table 3.2. Structural statistics of Kindlin 2 1-105 structure calculation. 
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Figure 3.6. Ramachandran plot of Kindlin 2 1-105 of the 20 lowest energy structures. 
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Figure 3.7. The overlay of the 100 lowest energy structures. 
 
 
 
Figure 3.8. Surface representation of the charges of the structure of Kindlin 2 1-105. 
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3.4. Structural comparison of Kindlin 1 and Kindlin 2 F0 domains.  
Kindlin 1 and 2 full length proteins share 62% sequence identity. The N-term 
residues 1-105 including the F0 domain of both proteins have a sequence similarity of 62 
%. Figure 3.13.(a) shows a sequence comparison between all N-term 1-105 sequences of 
Kindlin proteins.  
A closer look at the multiple sequence alignment of Kindlin proteins show a 
considerable similarity between residues 18-105 among all three sequences. The core 
structure is well conserved among Kindlin F0 domain within orthologs (Goult et al., 
2009).  A considerable difference is seen within the first 18 residues of Kindlin 2 
compared to the first 11 residues in Kindlin 1 and the first 16 residues in Kindlin 3.  
These sequences are drastically different in length and composition compared to the core 
structure and might account for potential differences in binding patterns. 
The N-terminal 1-18 residues show a right handed helical feature spanning 
residues 6-12 (13-19 residues in our construct). This feature is not present in Kindlin 1 
structure, in which the corresponding region is disordered. In addition to the helical 
feature in the N-terminus, there are two other significant differences between Kindlin 1 
and 2 structures: First is the turn between β1 and β2 strands. In Kindlin 2 it is a tight turn 
of four residues whereas in Kindlin 1 it comprise of nine residues. See figure 3.9.(b). The 
assignment of residue D33 in the turn of Kindlin 2 is missing. The helices α1 and α2 have 
equal lengths in Kindlin 1 and 2 F0 domain, which are 13 and 5 residues respectively. 
Both helices are right handed with similar orientation angles. The second major  
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 (a) 
   
(b) 
Figure 3.9. (a) Multiple sequence alignments of residues 1-105 of Kindlin 
proteins. K1=Kindlin 1, K2=Kindlin 2, K3=Kindlin 3. The sequence alignment 
was obtain using Clustal W software, which is the most commonly used softare 
for the alignment of multiple residues. (b) Overlay of Kindlin 1 and 2 solution 
NMR structures. Blue-Kindlin 1 and red-Kindlin 2 F0 domains. Despite the 60% 
sequence similarity, the globular fold is the same. Minor differences are observed 
between the two structures. 
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difference between Kindlin 1 and 2 F0 structures is the length and position angle of the 
beta strands. β1 and β2 beta strands in Kindlin 1 and 2 have equal lengths and 
orientations except the beta hairpin turn, which is different in the number of amino acids. 
In Kindlin 2 F0 domain, the β3, β4 and β5 strands are slightly different in orientation 
angles and lengths compared to Kindlin 1 F0 domain. Minor differences between the two 
structures may account for the functional differences between the F0 sub-domains of the 
two proteins.  
 
3.5. A Model 3D structure for full length Kindlin 2 protein. 
Kindlin 2 is a relatively novel protein, which has not been studied extensively 
although it plays a significant role in homeostasis. Neither its structural details nor 
structure based functions have been reported so far making it difficult to evaluate its 
function at a molecular level. The current information available on the full length Kindlin 
2 protein is its primary sequence and its predicted secondary structure. It is difficult to 
understand the potential function of Kindlin 2 merely from its primary and secondary 
structure. A tertiary structure of a protein gives much more insight to its function. 
Determining the tertiary structure of a protein is a complex process which requires time 
and expertise skills. Generating or predicting model 3D structures from the protein 
sequence has become a common task. Model structures give insight to the structure, may 
help us to understand its function/potential function and assist in designing projects 
accordingly. With the increasing availability of free accessible web servers and fast 
computers, obtaining model structures for proteins is nowadays a common task. 
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Robetta/Rosetta and i-Tasser are few of those widely used servers for computer generated 
prediction of model structures from the primary protein sequence.  
To have a better view on the full length Kindlin 2 protein, we obtained a model 
structure from Robetta protein structure prediction server at http://robetta.bakerlab.org. 
The full length amino acid sequence residues 1-680 of Kindlin 2 was submitted to the 
server for automated structure prediction. The server uses comparative modeling and de 
nova structure prediction methods to create subdomain models, which are pooled together 
to create the lowest energy models structures. (Kim et al., 2004). Several lowest energy 
model structures were generated and are shown in Figure 3.10. All structures show 
similar domain structures but slightly different orientations. These models show a 
multiple domain globular fold structure. The putative PH domain is surrounded by other 
domains of Kindlin 2. The F2 subdomain is split by the PH domain which is consistent in 
all model structures and comparable with literature. The bipartite F2 and F3 show tight 
packing against the PH domain. The model structure shows close proximity between the 
Kindlin 2 F0 domain and F2 subdomain.   
Model 1 is the lowest energy structure. We are interested to understand which of 
these models may be the closest to the accurate structure. Dr. Koichi Fukuda, a member 
in our laboratory, was able to obtain Kindlin 2 PH domain protein and kindly provided it 
for my experiments. The only two subdomain proteins of Kindlin 2 available are the F0 
and the PH domain. The proximity of the PH and F0 domain is different in each model 
structure and we questioned whether there is an interaction between the two subdomains. 
 
 60 
             (a)  (b)  
         (c)                  (d) 
    (e) 
Figure 3.10. Lowest energy model structures for Kindlin 2 Full length 
protein predicted from the Robetta server. (a) Model 1 (b) Model 2 (c) 
Model 3 (d) Model 4 (e) Model 5. Blue-F0 domains yellow and red-F1 
domain, Cyan and magenta- F2, green- PH domain and grey-F3 
subdomain. 
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To evaluate whether there is an intermolecular interaction between F0 and PH 
domain, we performed a HSQC NMR experiment. The HSQC spectra were recorded for 
0.1mM 1H-15N Kindlin 2 1-105 and in the presence of 0.2mM Kindlin 2 PH domain. The 
superimposed spectra are shown in Figure 3.19 and display no significant peak 
perturbations. This implies that the interaction between PH domain and F0 domain is not 
significant. Observing all the model structures we excluded the possibility that model 1 is 
precise since the PH domain and the F0 domains are in close contact in model 1 structure. 
It leaves us with the possibility that model 2-5 may be close to the actual structure of 
Kindlin 2. However, it could also be reasoned that although spatially close there might be 
no significant interaction between Kindlin 2 F0 and PH domains.  
 
3.6. Summary of chapter 3 results. 
To summarize, Kindlin 2 1-105 solution structure is the first piece of atomic level 
information obtained for Kindlin 2 protein. The difficulty of getting soluble and high 
yielding protein for the full length protein and its subdomains slows down structural and 
functional analyses.   Despite the 60% sequence similarity, Kindlin 2 1-105 structure 
adopts a similar fold to Kindlin 1 1-95 structure. The fold of both proteins is an ubiquitin-
like beta grasp fold with a 10 residues long alpha helix which is surrounded with 5 beta 
strands. The solution structures of Kindlin 1 and 2 N terminal F0 domains show minor 
differences from each other and these structural differences may be useful to relate them 
to their potential function/s. 
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Figure 3.11. 1H-15N HSQC spectra of 15N Kindlin 2 0.1 mM 1-105 in the 
absence (black) and presence (red) of 0.2mM Kindlin 2 PH domain 
showing no interaction of 15N Kindlin 2 1-105 and Kindlin 2 PH 
domain. 
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CHAPTER IV 
 
INTERACTIONS OF KINDLIN 2 F0 DOMAIN  
 
4.1. Overview 
The function of a protein is related to its three dimensional structure of the 
protein. We have solved the solution structure of Kindlin 2 F0 domain. Kindlin 1 and 2 
F0 domains share > 60% sequence homology and adopts a similar 3D fold. It could be 
assumed that the functions of the Kindlin 1 and 2 F0 domains are similar. However, the 
function of Kindlin 1 F0 domain (Goult, B. T., 2009) has not been elucidated up-to-date. 
Having the structure the next step is to understand the function/s of the F0 domain.  
This chapter describes several binding interactions of Kindlin 2 F0 domain. Altogether, 
we suggest a potential role of Kindlin 2 F0 domain in the process of integrin activation.  
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4.2. Kindlin 2 N-terminal – a domain essential for Kindlin and Talin mediated 
integrin activation 
The N-ter region of Kindlin 2 is known to interact with ILK and Migfilin (Tu et 
al., 2003). However the role of the F0 domain of Kindlin 2 has not been functionally 
characterized and there is no information in literature about the function of Kindlin N 
terminal or F0 domain.  
Kindlin proteins (in particular the C terminal FERM domain) bind to integrin β 
CT and play a cofactor role in integrin activation (Goult et al., 2009; Harburger et al., 
2009; Larjava et al., 2008; Ma et al., 2008; Montanez et al., 2008; Moser et al., 2009). To 
understand whether there is a functional significance of Kindlin 2 F0 domain in integrin 
activation, an integrin activation assay was performed in collaboration with Dr. Yang-
Qing Ma in Dr. Ed. Plow laboratory. 
In here, a particular focus was given to compare the effect of the full length 
Kindlin protein and F0 domain deleted full length Kindlin 2 in integrin activation. We 
transferred the corresponding constructs into EGFP vectors. The constructs were 
transfected into CHO cells, which stably express αIIbβ3 integrins. Activation of integrins 
was measured based on PAC1 binding, an antibody which only binds to activated 
integrins. To understand the role of Kindlin 2 in Talin induced integrin activation, Talin-
H-EGFP constructs were co-transfected to CHO cells. Talin H domain is a considerably 
stronger co-activator of integrin than full length Talin (Goksoy et al., 2008).  
The data summarized in Figure 4.1. are results from 3 independent experiments 
showing that there is more than a two fold activation of integrins in the presence of 
Kindlin 2 compared to Talin H alone. Integrin activation with Kindlin 2 alone shows a 
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much weaker activation than Talin H alone (Ma et al., 2008). By comparison, there is a 
substantial decrease in integrin activation in residues 11-143 deleted Kindlin 2 construct. 
The same was true for 1-105 deleted Kindlin construct (data not shown). Previous studies 
have indicated that Kindlin-2 1-263 was important for integrin activation but now we 
further narrowed down to 1-105 region. These data have highlighted the importance of 
Kindlin N-ter in integrin activation. Further it is evidenced that Kindlin F0 plays a central 
role in integrin activation.  
 
Figure 4.1. The effect of Talin head domain, Talin head - Kindlin 2 and 
Talin head – Kindlin 2  11-143 in integrin activation. CHO cells which 
are stably expressing αIIbβ3, were transfected with cDNAs of Talin head 
domain, Talin head- Kindlin 2 and Talin head – Kindlin 2 ∆ 11-143. The 
EGFP positive cells were gated and used to monitor PAC-1 binding/integrin 
activation (Ma et al., 2008). 
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4.3. Kindlin 2 N-ter and integrin interaction 
Knowing the structure of Kindlin 2 1-105 and its functional significance in vivo, 
we questioned the role of Kindlin 2 N-ter in integrin activation. There is evidence from 
literature for direct interaction of Kindlin 2 C-ter with integrin (Shi et al., 2007; Ma et al., 
2008; Bledzka et al., 2010). Deletion of Kindlin 2 1-218 or 1-345 from full length 
Kindlin disrupts the interaction with integrin CT (Ma et al., 2008). To investigate whether 
Kindlin 2 F0 domain (1-105 residues) interact with the integrin CT, we performed a 
series of experiments using NMR. HSQC-NMR is the most simple, quick, informative 
and straightforward experiment to examine the interaction between two proteins. 
Integrin CT peptide residues K716-T764, has been widely known for its low 
solubility at physiological salt concentration. Thus, the wild type peptide is difficult to 
use for NMR experiments with Kindlin proteins as the stabilizing buffer is 50mM 
Sodium phosphate and 100mM Sodium Chloride. Several modifications on the CT have 
been done to improve solubility and stability of the peptide (Goksoy et al., 2008; 
Wegener et al., 2007). One such modification from one of our group members, Dr. 
Jianmin Liu, was to mutate several N terminal hydrophobic membrane proximal Leucine 
residues. This has dramatically improved the stability and solubility of the peptide.  
Figure 4.2 shows the HSQC of two superimposed spectra, the HSQC of 0.1 mM 
15N-D β3 integrin mutant CT in the presence of 0.2mM Kindlin 2 1-105 in red and in 
black the free form (15N-D β3 mutant). Several peaks have been shifted giving direct 
evidence for interaction between the two molecules. The same peaks have perturbed for 
Kindlin 2 11-143 interaction (data not shown). Mapping the perturbed residues on  
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Figure 4.2. 1H-15N HSQC spectrum of integrin 15N-D β3mutant CT and 
Kindlin 2 1-105 interaction. An overlay of the 1H-15N HSQC spectra of β3 
integrin CT mutant (in black) and β3 mutant in the presence of Kindlin 2 1-
105 (in red) at 1:2 molar ratio.  
 
integrin revealed that the very N-terminal stretch of residues and several residues in the 
linker region are involved in the interaction (Shown in Figure 4.3.). 
The reverse NMR experiment of 15N Kindlin 2 1-105 and unlabelled β3 integrin 
CT mutant was performed at a 1 to 2 excess molar ratio. Data shown in Figure 4.4 
suggests a very weak interaction with small peak shifts. β3 integrin CT wild type His 
fusion protein and β3 integrin wt MBP fusion protein have a similar peak perturbation 
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pattern (data not shown). The perturbed residues on Kindlin 2 1-105 are shown in Figure 
4.3.   
 
GSSHHHHHHS SGLVPRGSHM 716KKKITIHDRK EFAKFEEERA 
AKWDTANNP LYKEATSTFT NITYRGT 
 
Figure 4.3. Perturbed residues of integrin CT sequence. The linker 
region is underlined. The β3 CT starts with 716K. The stretches of 
716KKKITIH and GLVP in the linker are essentially perturbed by Kindlin 2 
1-105 interaction highlighted in red. 
 
Although very weak, these data suggest that Kindlin 2 1-105 may be partially 
involved in binding to integrin (in addition to the major binding site by Kindlin-2 C-
terminal PTB domain).  The full structure of Kindlin-2 is not available, however, 
examination of the model structures suggest that the N- and C-terminus of Kindlin-2 are 
spatially close (Fig 3.10) so integrin β3 CT might bind to both regions. Such binding 
mode may enhance the tighter association of Kindlin 2 with integrin.  
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Figure 4.4. 1H-15N HSQC superimposed spectra of 15N Kindlin 2 1-105 
and unlabeled β3 integrin CTmutant interaction. The red peaks 
correspond to 15N Kindlin 2 1-105 in the presence of β3 CT at 1:2 molar 
ratio.  The black peaks correspond to 15N Kindlin 2 1-105 HSQC spectrum. 
The peaks shifts are observed at 1:2 excess molar ratio are small but 
consistent among repeated experiments. 
 
Figure 4. 5. Ribbon diagram of Kindlin 2 1-105 highlighting perturbed 
residues due to integrin interaction. The most perturbed peaks are 
confined to one area of the molecule.  
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4.4. Kindlin 2 N’ and membrane interaction 
As revealed above, functional data show that Kindlin 2 1-105 plays an important 
role in integrin activation and in vitro NMR data supports that integrin CT interacts with 
Kindlin 2 F0 domain. The membrane N-ter residues that have perturbed belong to the 
very proximal residues of the integrin beta3 CT. For such interactions in vivo, Kindlin 2 
F0 domain should come in close contact with the membrane. We reasoned whether there 
is a secondary interaction between the membrane and Kindlin F0 which may help to 
stabilize the interaction between Kindlin F0 and integrin.  
To investigate our hypothesis, we used NMR as our tool for analysis. In order to 
create a membrane mimetic environment, LUV, large unilamellar vesicles of 
phosphoinositides with 25% PIP2 were provided from one of our group members, Dr. 
Jun Yang.  These form the necessary membrane surface for analysis. We added LUV at 
1:5, 1:10 and 1:20 molar ratios to 15N labeled Kindlin 2 1-105 protein and HSQC spectra 
of Kindlin were recorded in the presence and absence of LUV’s. Data are shown in 
Figure 4.6 reveal a weak interaction between the membrane and Kindlin F0 even at low 
molar ratio. 
This piece of information confirms that Kindlin 2 F0 domain interacts with the 
membrane weakly. This supports our hypothesis that Kindlin 2 F0 may stabilize the 
interaction between integrin and Kindlin F0 by tethering to the membrane. As mentioned 
above, Kindlin 2 also contains a PH-like domain that may bind to phosphoinositides to 
facilitate the kindlin-2/membrane association. Our collaborator Cary Wu has recently 
found that Kindlin 2 does potently bind to PIP3 and such binding seems to be important 
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for Kindlin 2 mediated integrin activation (Qu et al., submitted). I therefore measured the 
Kindlin 2 PH  
  (a) 
(b)    (c) 
          (d) 
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(e) 
Figure 4.6. 1H-15N HSQC spectra showing interaction of 15N Kindlin 2 
1-105 and LUV/PIP2. (a) An overlay of spectra of black – free form of 
Kindlin 1-105, red – complex of Kindlin 2 1-105 and LUV at 1-5 molar 
ratio, green – complex of Kindlin 2 1-105 and LUV at 1-10 molar ratio, blue 
- complex of Kindlin 2 1-105 and LUV at 1-20 molar ratio. (b) and (c) 
zoomed images of (a). (d) is the 1H-15N HSQC of the interaction between 
Kindlin 2 1-105 and PIP3(C16). (e) Ribbon diagrams Kindlin 2 1-105 
representing and highlighting perturbed residue side chains due to 
membrane interaction in green and PIP3 interaction in pink. 
 
domain, (kindly provided by Dr. Koichi Fukuda) binding to PIP3 using SPR experiment, 
which revealed the Kd~1µM (Appendix 5). Thus, Kindlin 2 may use its multiple domains 
including F0 and PH-like domain to associate with membrane to facilitate the Kindlin-
2/integrin interaction. Structural and functional analysis of filamin/integrin complex 
(Kiema et al., 2006) showed that filamin is a negative regulator of integrin activation. 
Interestingly, the filamin binding site on integrin seems to mask both Talin and Kindlin 2 
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binding (Figure 4.7.). Thus, one possible mechanism for the co-activation of Kindlin 2 
and Talin is that they both compete with Filamin and promote the integrin activation. The 
membrane association of Kindlin 2 may tether the Kindlin 2 binding to integrin tail to 
enhance the kindlin-2 effect (Figure 4.7.). 
  
Figure 4.7. Integrin beta CT sequences showing Talin, Filamin and 
Kindlin binding sites. Filamin binding site on integrin partially overlaps 
with Kindlin PTB and talin binding sites (slide adopted from Dr. Mitali 
Das). 
 
4.5. Summary of chapter 4 results 
To summarize, as described throughout the chapter, Kindlin 2 F0 domain plays a 
significant role in integrin activation. Deletion of F0 domain abolished the contributory 
effect in Talin induced integrin activation due to full length Kindlin 2. Thus F0 domain 
itself plays a very important role in integrin activation. How F0, PH and F3 domains 
cooperate in integrin activation needs to be further investigated at atomic level.  
From binding interaction studies Kindlin 2 F0 domain interacts with PIP2/membrane and 
integrin β3 CT tails. Interestingly the interaction sites or residues of Kindlin 2 F0 domain 
are non-overlapping.  
 
Filamin 
 
 
Talin 
 
Kindlins 
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CHAPTER V 
 
INTERACTIONS STUDIES OF KINDLIN 2 AND MIGFILIN 
 
This chapter addresses aim 3. The role of Kindlin 2, together with its potential 
interacting partners, is evaluated in the complex process of integrin activation. The first 
section (5.1.) investigates the interaction between Kindlin 2 and Migfilin. A detail 
analysis of Kindlin 2 and Migfilin interaction/s is evaluated to understand its role in the 
focal adhesion complex. The second section (4.2.) investigates the global role of Migfilin, 
Kindlin 2 and Talin H in integrin activation.  
 
5.1. Kindlin 2 and Migflin interaction – a necessary link in focal adhesions. 
5.1.1. Introduction 
It has been shown in literature that Kindlin 2 interacts with Migfilin (Tu et al., 
2003; Wu, 2005). The interaction between Kindlin 2 N-ter and Migfilin is required to 
recruit Migfilin to focal adhesion site (Tu et al., 2003). Based on our model of integrin 
activation (Chapter 1, Figure 1.6.), the recruitment of Migfilin is a necessary step for the 
removal of bound Filamin from the integrin β CT. The accessibility of integrin CT for 
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binding is the most important and initial step in the process of integrin activation. 
Migfilin N-terminal 1-36 residues bind to Filamin, removing Filamin from the CT.  At 
resting/inactive states of integrins Filamin is bound to integrin CT and masks Talin H and 
Kindlin 2 binding sites on the integrin tail demonstrating the negative regulatory effect of 
Filamin in integrin activation (Kiema et al., 2006; Ithychanda et al., 2009a and b; Wu, 
2005). Removal of Filamin from integrin allows Talin H and Kindlin to bind to CT and 
promote subsequent activation of integrins (Chapter 1, Figure 1.6). 
Based on the facts in literature, (a) Kindlin 2 plays a role in recruiting Migfilin to 
focal adhesion site and (b) Kindlin 2 may also play a role in integrin activation. It is not 
clear how Kindlin performs both these functions. As the initial step of understanding the 
central role of Kindlin 2 in the complex process of integrin activation, we investigated the 
interaction between Kindlin 2 N-terminal and Migfilin. To pinpoint the binding surfaces 
and further understand the role of Kindlin 2 N-terminal sequences we initiated to 
investigate the interaction between Kindlin 2 and Migfilin using Kindlin 2 F0 domain 
protein as a starting point. The following sub-chapter provides an outline of the 
experiments and results of the binding interactions of Kindlin 2 and Migfilin. 
 
5.1.2. Kindlin 2 N-ter and Migflin interaction  
The interaction between Kindlin 2 and Migfilin is mediated through the LIM 
domains of Migfilin (Tu et al., 2003). Unpublished in vivo data from our collaborator, Dr. 
Cary Wu, show that the interaction is abolished upon deletion of residues 1-218 of 
Kindlin 2. This demonstrates that Kindlin 2 N-terminal region is responsible for the 
interaction between Kindlin 2 and Migfilin.  
 76 
The N-term region of residues 1-218 of Kindlin 2 mainly comprises of the F0 sub-
domain and partial F1 sub-domain. As a starting point, to investigate the interaction 
between Kindlin 2 and Migfilin, we speculated whether there is an interaction between 
Kindlin 2 and Migfilin via the N-terminal 1-105 residues (F0) of Kindlin 2 and LIM 
domains of Migfilin. We used NMR as our tool for initial analysis.    
We cloned Migfilin LIM domains separately and in all possible combinations into 
pHis-1 and pGEX-4T-1 vector. These are: Migfilin LIM123, LIM23, LIM12, LIM1, 
LIM2 and LIM3.  All His fusion tag constructs were completely insoluble. The GST 
fusion proteins were soluble and further optimization revealed that 15 º C inductions gave 
a very high yield of soluble protein. Figure 5.1 shows the HSQC spectra of all LIM 
domain proteins of Migfilin. The spectra of LIM1 and LIM2 proteins show well spread 
peak distribution implying a properly structured protein. Surprisingly, the peaks of the 
HSQC spectrum of Migfilin LIM3 are confined into a narrow range around 8ppm of the 
1H-scale. This demonstrates that LIM3 is an unstructured protein. More interestingly, the 
HSQC spectrum of LIM23 domain does not show peak crowding around the center 8ppm 
(see figure 5.3.(e)). The spectrum of Migfilin LIM23 shows almost a twice as much of 
peaks compared to LIM2 domains itself. This shows that LIM3 domain adopts a 
structured fold in the presence of LIM2 domain. Therefore all experiments were carried 
out using Migfilin LIM23 domain instead of LIM2 and LIM3 separately.  
To investigate the potential interaction between Kindlin 2 1-105 and Migfilin 
LIM domains we performed a series of 1H-15N 2D HSQC experiments. HSQC is the most 
sensitive experiment, which is able to detect interactions between wide ranges of binding  
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   (a)     (b) 
 
(c) 
Figure 5.1. 1H-15N HSQC of all Migfilin LIM domains. (a) shows the 
HSQC spetrum of Migfilin LIM 1 domain (b) of Migfilin LIM2 domain 
and (c) of Migfilin LIM 3 domain respectively. (a) and (b) spectrums 
show a distribution of peaks which correlates to a well folded protein 
whereas in (c) spectrum most peaks are centered around 8 ppm which 
implies a partially unstructured   protein.  
 
affinities from milli molar to nano molar. To initiate the experiments I added an 
unlabeled Migfilin LIM23 domain protein into 15N labeled Kindlin 2 1-105 protein at a 
1:2 molar ratio. Each peak in the HSQC spectrum for Kindlin 2 1-105 corresponds an 
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amino acid in the protein, more precisely each peak in the HSQC spectrum reflects a 
correlation between amide proton and directly attached 15N group of the protein. Any 
change in peak position, peak broadening or peak disappearance of Kindlin 2 1-105 
HSQC spectrum upon adding the interacting partner Migfilin LIM23, resembles a change 
in the chemical environment of the residue. This implies an interaction between the two 
interacting partners.  Our assumption was that if there is any interaction between Kindlin 
2 1-105 and Migflin LIM23 proteins, it should reflect as peak perturbations or peak 
broadening or disappearances in the HSQC spectrum. The recorded HSQC spectrum is 
shown in figure 5.2. No significant peak perturbations were observed between Kindlin 2 
1-105 and Migfilin LIM23 / LIM1 domains at 1-2 molar ratios suggesting no interaction 
between Kindlin 2 1-105 and Migfilin LIM 23/1 domains.  
To further confirm our conclusion we performed a series of NMR experiments by 
performing the reverse experiments. I recorded HSQC experiments of 15N labeled 
Migfilin LIM1 and LIM23 in the presence and absence of unlabeled Kindlin 2 1-105 
protein. The superimposed spectra were evaluated for peak position changes. These data 
show no significant peak perturbations, confirming that there is no interaction between 
Kindlin 2 1-105 and Migfilin LIM domains.  
To summarize, NMR data from figure 5.2., reveal that there is no interaction of 
the first 105 residues of Kindlin 2 and Migfilin LIM domain. However, in vivo assays 
have shown a strong interaction between Kindlin 2 1-218 (data not shown) and Migfilin  
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(a) 
 
(b) 
Figure 5.2. 1H-15N HSQC of Kindlin 1-105 and Migfilin LIM domains. 
(a) Interaction between 15N labeled Kindlin 2 1-105 and unlabeled 
Migfilin LIM23 domain. (b) Interaction between 15N labeled Kindlin 2 1-
105 and unlabeled Migfilin LIM1. Both spectra show no significant peak 
perturbation implying no significant interaction between the proteins.  
 80 
LIM domains. Therefore, we assume that the interacting site between Migfilin and 
Kindlin 2 is beyond residues 105 of Kindlin 2. 
To evaluate the effect of the residues between 105 and 218 of Kindlin 2 on the 
interaction with Migfilin LIM domains, we engineered a number of protein expression 
constructs beyond this region. All these constructs were engineered carefully selecting 
boundaries according to the model structure of Kindlin 2. The constructs details, their 
expression and solubility are summarized in table 3.1. Most of the constructs within 105-
218 of Kindlin 2 had either low expression of the target protein or the expressed protein 
was in the insoluble fraction of the cell. Kindlin 2 11-143 construct had a low expression 
and a yield of <1mg per Liter of LB culture. The 15N labeled protein yield was even 
lesser but we are able to obtain a sufficient amount for NMR experiments by growing 
cultures in larger scales.  To test our hypothesis, a series of HSQC experiments were 
performed using 15N labeled Kindlin 2 11-143 and Migfilin LIM23 domains and vive 
versa. The results are shown in figure 5.3.  
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(a) 
      
   (b)      (c) 
 
(d) 
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(e) 
(f) 
Figure 5.3. 1H-15N HSQC between Kindlin 2 11-143 and Migfilin Lim23 
at 1:2 molar ratios. All experiments were performed at pH 6.89 in 50mM 
sodium phosphate and 100mM Sodium chloride. Spectrum (a) shows the 
interaction between 15 N labeled Kindlin 2 11-143 and unlabeled Migfilin 
LIM23 domains. Spectrum (b), (c) and (d) are zoomed images of (a). (e) 
Shows the reverse experiment using 15N labeled Migfilin Lim23 domain and 
unlabeled Kindlin 2 11-143 protein. (f) Ribbon diagram of Kindlin2 1-105 
highlighting some perturbed residues (23-25 and 83-85 residues) due to 
Migfilin LIM23 interaction. The HSQC spectra of Kindlin 2 1-105 and 11-
143 are not 100% overlapping. 
 83 
 
The spectrum shown in 5.3.(a) and zoomed images (b), (c) and (d), clearly show 
significant peak perturbations. A 1:1 molar ratio interaction perturbed the same peaks as 
in 1:2 but to a lesser extend. Thus the interaction occurs in a dose dependant manner. 
This clearly evidences weak interaction between Kindlin 2 11-143 and Migfilin LIM23 
fragments with a weak affinity between the two molecules.   
The HSQC spectra of Kindlin 2 11-143 and 1-105 are different. However there 
are some peaks that are overlapping. We correlated some of the perturbed peaks to 
Kindlin 2 1-105 structure. We could clearly see, as shown in Figure 5.3.(f), that peak 
clusters of residues 23-25 and 83-85 are perturbed.   
To investigate whether Migfilin LIM1 has an effect (in addition to LIM23) on the 
interaction between Kindlin 2 11-143 and Migfilin LIM domains, we cloned all LIM 
domains (LIM123) into pGEX-4T-1 vector. Although the expression was reasonable, the 
protein was unstable and tends to precipitate during the purification process. We were 
unable to obtain a sufficient amount to perform NMR experiments. However, Migfilin 
LIM 1 itself is a stable protein. Next, we were interested to understand whether LIM 1 
domain of Migfilin has a contributory effect for the interaction between Migfilin and 
Kindlin 2 11-143. The HSQC spectrum of 15N Kindlin 2 11-143 and that in the presence 
of a two fold  excess molar ratio of Migfilin LIM 1 were superimposed and analyzed for 
any apparent peak perturbations. The spectra shown in figure 5.4 clearly show that there 
are no peak perturbation implying that the interaction between Kindlin 2 11-143 fragment 
and Migfilin LIM 1 domain is insignificant. This experiment narrows down the binding 
domains of Migfilin to LIM23 and residues 11-143 on Kindlin 2.  
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In vivo assays have shown a strong interaction between Kindlin 2 1-218 (data not 
shown) and Migfilin LIM domains. To evaluate whether the binding site is further 
expanded beyond residue 143 in Kindlin 2, we needed an expression construct 
encompassing residues 143-218. 
 
 
Figure 5.4. 1H-15N HSQC superimposed spectra showing the interaction 
between Kindlin 2 11-143 and Migfilin LIM 1 at 1:2 molar ratio. The 
black spectrum corresponds to 1H-15N HSQC of Kindlin 2 11-143 and red 
spectrum is the HSQC acquired of Kindlin 2 11-143 in the presence of 
Migfilin LIM 1 domain.  
 
An expression construct for Kindlin 2 95-268, engineered using pGST-1 vector, a 
pGEX-4T-1 derived vector, had a very poor expression of the protein. Residues 95-268 
of Kindlin 2 consist of partial F1 sub-domains and parts of F2. Optimization on 
temperature of induction, time of induction etc, did not improve the expression. I made 
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two smaller constructs by subdividing residues 95-268 into 95-168 and 168-268. I chose 
these boundaries according to the Kindlin 2 model structure. Kindlin 2 95-168 protein 
was a complete aggregate in size exclusion chromatography (with and without the fusion 
tag). We were able to isolate Kindlin 2 168-268 as a GST fusion protein at its dimeric 
state. To investigate the interaction between Migfilin and Kindlin 2, I performed a 2D 
HSQC experiment.  The spectra of Migfilin LIM23 were recorded in the absence and 
presence of Kindlin 2 168-286-GST fusion protein. The data are shown in Figures 5.5.  
 
 
Figure 5.5. 1H-15N HSQC superimposed spectra of the interaction 
between 15N Migfilin LIM23 and Kindlin 2 168-268-GST 
 
As a control experiment, I recorded a HSQC experiment with GST protein as the 
interacting partner, at a 1:2 molar ratio in the presence of 15N Migfilin LIM23. A 
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prominent chemical shift pattern is seen in the control spectra representing the influence 
of the GST tag on Migfilin LIM23 domain.  
After cleavage of the GST tag from Kindlin 2 168-268-GST fusion protein, a 
majority of the cleaved protein tend to aggregate, while a much smaller fraction co-eluted 
with the dimerized GST tag when subjected to size exclusion chromatography.  Although 
low in yield, Kindlin 2 168-268 protein is a tetramer.   
 
Figure 5.6. 1H-15N HSQC superimposed spectra of 15 N Migfilin 
LIM23 in black and 15 N Migfilin LIM23 in the presence of Kindlin 2 
168-268 in red.  
 
The superimposed HSQC spectra between 15N Migfilin LIM23 and Kindlin 2 168-
268 in the presence of 15N Migfilin LIM23 are shown in Figure 5.6. No significant peak 
perturbations are observed in figure 5.6 which again implies that there is no significant 
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interaction between Kindlin 2 168-268 and Migfilin LIM23 domains. The positive effect 
seen earlier in figure 4.5 was due to the GST fusion tag.  
Since, in vivo assays have shown an interaction between Kindlin 2 N-ter and 
Migfilin LIM domains, we predicted that the remaining untested fragments of Kindlin 2 
N-ter are responsible for the interaction. Unfortunately, Kindlin 2 95-168 fragment, 
which is a region untested for the interaction, is completely aggregating. A closer look at 
the amino acid sequence of Kindlin 2 95-168 revealed that there is a stretch of positively 
charged lysines followed by alternating negatively charged amino acids. We rationalized 
that this region may be the leading cause for aggregation. I made two shorter constructs 
of Kindlin 2, residues 95-154 consists of the positively charged amino acid stretch 
whereas residues 155-268 contains the negatively charged amino acids. Surprisingly, the 
expressed protein of Kindlin 2 95-154 aggregates completely, being unavailable for 
further analysis. Kindlin 2 155-268 behaves the same way as Kindlin 2 168-268 and is a 
tetramer in size exclusion chromatography.  A HSQC experiment with 15N Migfilin 
LIM23 and Kindlin 2 155-268 revealed no interaction.  
The only stretch of amino acids of Kindlin 2 N-terminal region that have not been 
tested for interaction with Migfilin LIM domains are residues 143-154. Having strong in 
vivo data from our collaborators for positive and strong interaction between Kindlin N-
terminal and Migfilin, we reasoned that residues 143 to 154 may impose binding. To test 
our hypothesis we synthesized a peptide of residues 143-154 which comprise of amino 
acids: KKPRDPTKKKKKKK. To investigate the nature of interaction between Migfilin 
LIM23 domain and the synthesized peptide, we performed a HSQC experiment, which is 
capable in detecting very weak interactions. Multiple HSQC spectra of 15N Migfilin 
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LIM23 domain protein with increasing molar ratios of the peptide were recorded.  The 
results shown in Figure 5.6 revealed no significant peak perturbations even at 1:4 molar 
ratios.To summarize, we tested residue 1-268 of Kindlin 2 for the interaction with 
Migfilin Lim domains. Among all the experiments, we have seen a weak interaction 
between Kindlin 2 11-143 and Migfilin LIM23 domains.   
 
Figure 5.7. Migfilin LIM23 with Kindlin 2 143-154 peptide. This is an 
overlay of HSQC spectra between 15N Migfilin Lim23 domain and that in 
the presence of Kindlin 2 143-154 synthetic peptide.  
 
The HSQC spectra of Kindlin 2 1-105 and 11-143 are not identical, but there are 
certain peaks that are partially overlapping. In order to get a vague idea of the distribution 
of the perturbed peaks by correlating them to the Kindlin 2 105 structure, we have seen 
that most of the perturbed peaks are common to both constructs. This leaves us with the 
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question whether the C-terminal residues 105-143 on Kindlin 2 has an effect on the 
functional structure. Tracing back some of the perturbed residues on Kindlin 2 11-
143spectrum to the solution structure of Kindlin 2 1-105 reveals that peak clusters have 
been perturbed. These are residues 23-25 and 83-85. A closer observation of the two 
sequences in the Kindlin 2 model structure shows that the C-terminal residues of 95-143 
are structured. As shown in figure 5.8, the F0 domain is highlighted in blue and parts of 
F1 sub-domain in yellow.  Figure5.8.(a) is the model structure Kindlin 2 1-105. Residues 
95-105 in (a) denote a C-terminal single beta strand whereas in (b), Kindlin 2 11-43 
construct, the C-terminal 95-143 sequences are structured in to an anti-parallel beta sheet  
          
(a) (b) 
Figure 5.8. (a) Kindlin 2 1-105 model structure and (b) Kindlin 2 11-143 
model structures in ribbon diagrams, obtained from Kindlin 2 model 1 
structure. The residues in blue correspond to 1-95 F0 domain and the 
residues in yellow correspond to 96-105 in (a) and 95-143 in (b). 
 
and a short helix. According to the solved 3D structure of Kindlin 2 1-105 (Chapter III), 
residues 100-105 are unstructured. There is a possibility that the C-terminal residues 
highlighted in yellow in (b) may influence a functional conformation on F0 domain. If so, 
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this might be a reason for the positive interaction between Kindlin 2 11-143 / Migfilin 
Lim23 domains and negative interaction between Kindlin 2 1-105 / Migfilin LIM23 
domains. It is quite evident that Kindlin 2 N-ter has a positive influence for Migfilin LIM 
domain interaction. In vivo studies used a larger fragments for analysis. But due to size 
limitation in NMR, fragmentation was a necessity. We cloned larger fragments of Kindlin 
2, but unfortunately, Kindlin 2 1-218 had no expression.  
To summarize, all data above suggest that there is a very weak interaction 
between Kindlin 2 full length/N-terminal and Migfilin LIM domains. According to our 
schematic representation of integrin activation, the link between Migfilin and Kindlin 
play a crucial role in the establishment of the link between the actin cytoskeleton and the 
extracellular matrix. Continuing evidence from in vivo studies from our collaborators has 
strong support for the interaction between Kindlin 2 N-ter and Migfilin. However, or 
NMR studies did not record a significant binding interaction further analysis are required 
to pin-point the binding interfaces.  
 
5.2. The role of Kindlin 2 and Migfilin in integrin activation.  
5.2.1.Introduction 
Migfilin and Kindlin are key molecules in the process of integrin activation. Talin 
H domain of Talin is a well known activator of integrins and the mechanism of Talin H in 
integrin activation has been widely accepted (Calderwood, 2004; Garcia-Alvarez et al., 
2003; Vinogradova et al., 2002) The importance of Kindlin in integrin activation has 
been recently implicated (Ma et al., 2008). Migfilin is known to bind to Filamin and 
Kindlin. The importance of the interaction between Migfilin and Filamin is well 
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established. The interaction between Migfilin and Kindlin is important to recruit Migfilin 
to the focal adhesion site (Tu et al., 2003). Besides, it is interesting to know how the 
interaction between Migfilin and Kindlin may affect in the process of integrin activation. 
To understand the role of Migfilin/Kindlin in the complex process of integrin 
activation, in collaboration, we performed a series of NMR, ITC, SPR and in vivo 
functional experiments, which will be analyzed and discussed throughout the next sub-
chapter.  
 
5.2.2. In vivo functional evidence for the role of Migfilin in Talin and Kindlin 2 induced 
integrin activation. 
A very recent in vivo study performed by Dr. Ma Yang-Qing in Dr. Ed. Plow Lab 
revealed a few important facts on the role of Migfilin in Talin and Kindlin 2 induced 
integrin activation. The results of the integrin activation assays are summarized in 
Figures 5.9 and 5.10 below. Each experiment shows the median of 3 experiments of 
PAC1 binding. PAC1 is a ligand for the binding of activated αIIbβ3 integrins. Figure 5.8 
shows that there is an enhanced activation of integrin in the presence of Migfilin-Talin 
H–Kindlin2 compared to Talin H-Kindlin 2 or Talin H alone. This clearly shows the 
positive role of full length Migfilin in Talin H and Kindlin2 induced integrin activation. 
Figure 5.8 further shows that integrin αIIbβ3 activation is diminished in the 
presence of over-expression of only Migfilin-Kindlin2 (last lane). This further supports 
the well-established role of Talin H in integrin activation and confirms that Talin H is the 
key molecule to propagate integrin activation. 
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The functional role of Kindlin2 in Talin induced integrin activation was 
heightened in Figure 5.9.-lane 5. Over-expression of Migfilin and Talin H show the same 
level in PAC1 binding to activated integrins compared to Talin H. This implies that 
Migfilin has no effect on enhancing the effect of integrin activation without Kindlin 2. In 
other words, the interaction between Kindlin and Migfilin may play a significant role in 
integrin activation. 
To summarize the data in figure 5.9: TalinH is sufficient for the activation of 
integrins. Kindlin and Migfilin have a cofactor effect for the role in Talin induced 
integrin activation. The interaction between Kindlin and Migfilin is necessary to show the 
effect of Migfilin in integrin activation.  
 
Figure 5.9. Integrin activation assay. Effect of Migfilin on Talin and 
Kindlin 2 induced integrin activation. CHO cells are stably expressing 
αIIbβ3, transfected with cDNAs of each Talin head domain, Talin head- 
Kindlin 2, Talin head – Kindlin 2-Migfilin, TalinH-Migfilin and Kindlin2 and 
Migfilin (Ma et al., 2008). 
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Migfilin is an adaptor protein comprising of 373 amino acids. Structurally, the C-
terminal LIM domains have shown to mediate the interaction with Kindlin (Tu et el, 
2003). The unstructured N-terminal region interacts with Filamin and act as a negative 
regulator in integrin activation (Ithychanda et al., 2009b; Ithychanda et al., 2009c). The 
central proline rich region has two binding sites for Src and VASP. Migfilin is the 
initiator of the Src pathway and prevents and protect against apoptosis (Zhao et al., 
2009). To investigate the effect of each domain of Migfilin in the role of Migfilin in 
integrin activation, another integrin activation assay was performed by Dr. Ma, Yang-
Qing, incorporating Migfilin sub-domain proteins (Figure 5.10.).   
Migfilin(s) is an isoform of Migfilin, which lacks the proline rich region. To evaluate the 
functional role of the proline rich region in integrin activation Migfilin(s) isoform was 
overexpressed and the extent of αIIbβ3 binding was monitored. Similarly, the effect of 
Migfilin 1-85 and the C-terminal LIM domains were monitored and the data are shown in 
Figure 5.10. According to the figure, a significant decrease in PAC1 binding could not be 
observed for Migfilin(s), demonstrating that the proline rich region of Migfilin has no 
contributory effect in integrin activation. 
Figure 5.10 shows deletion of N and/or C terminal domains, reduce PAC1 binding 
heightening the importance of both regions as a cooperate role in integrin inside-out 
signaling mechanism. 
 
 94 
 
Figure 5.10. Integrin activation assay. Effect of Migfilin subdomains on 
Talin and Kindlin 2 induced integrin activation. CHO cells are transfected 
with cDNAs of each Talin head domain, Talin head- Kindlin 2, Talin head – 
Kindlin 2-Migfilin(s), TalinH-Migfilin and Kindlin2 and Migfilin Nterminal 
1-85residues, TalinH-Migfilin and Kindlin2 and Migfilin C-terminal LIM 
domains (Ma et al., 2008) 
 
Migfilin N-terminal 1-85 residues are well known to bind to Filamin, thereby 
removing Filamin from integrin CT and makes integrin available for potent activation by 
Talin and Kindlin 2 (Ithychanda et al., 2009a; Ithychanda et al., 2009b) (Lad et al., 2008; 
lad et al., 2007). Over expressing Migfilin N-terminal 1-85 in CHO cells would remove 
Filamin from integrin tails allowing the CT available for potential activation by Talin and 
Kindlin. Being the only negative regulator identified to remove Filamin from integrin CT 
tail; Migfilin N-terminal region plays a very important role to initiate the process of 
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integrin activation. Interestingly, the LIM domains of Migfilin show an equal importance 
in integrin activation. The only known link of Migfilin LIM domains is its interaction 
mediated by Kindlin 2. Kindlin 2 protein recruits Migfilin to the focal adhesion site, 
allowing it to regulate the inhibitory effect of Filamin (Tu et el, 2003). 
To summarize, this assay demonstrates the functional importance of both C and N 
terminal of Migfilin for integrin activation and deleting either of it would substantially 
diminish integrin activation. 
Despite the role in recruiting Migfilin to FA, Kindlin also interacts with integrin 
to heighten the effect of integrin activation. In focal adhesions, Talin H, Kindlin 2 and 
Migfilin are spatially close. NMR data have shown that there is no interaction between 
Kindlin F0 and Talin H domain. We questioned, whether there is a secondary interaction 
between Migfilin and Talin H. We hypothesized, whether Migfilin bridges Talin H and 
Kindlin N-ter and thereby forming a ternary complex, which may stabilize the interaction 
with integrin. The next subchapter evaluates our hypothesis through a series of NMR and 
SPR experiments.  
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5.2.3. The relationship between Migfilin and Talin interaction  
To test our hypothesis introduced in the previous subchapter, we performed a 
series of HSQC, in vivo and SPR experiments. These help us to understand the 
interaction between Talin H and Migfilin subdomains.  
The first step was to obtain Talin H and subdomain proteins to perform 
interaction experiments. I subcloned Talin H domain and its subdomains into pHis-1 
vector as explained in chapter II -methods and materials section. After expression and 
purification of the proteins, I performed a 2D-HSQC experiments between 15N labeled 
Talin His fusion proteins and unlabeled Migfilin LIM and vice versa. Data summarized in 
figure 5.11 show a site specific interaction between Migfilin LIM domains and all 15N 
labeled his tag-Talin subdomains: TalinH, TalinF0F1, TalinF0 and TalinF1. The 
chemical shifts were dose dependant. The reverse experiments of 15N labeled Migfilin 
LIM domains and unlabeled Talin subdomains were positive. To further confirm this 
interaction, I performed an SPR analysis. The results revealed a very weak interaction 
between Talin F0F1 and Migfilin LIM domains with a 40µM and 3µM affinity for Talin 
F0F1 and F0 domains respectively.  
I performed another group of experiments without the His tag of Talin subdomain 
proteins and Migfilin LIM domains.  Interestingly, the interaction was completely  
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(a)           (b) 
    
(c) 
Figure 5.11. 1H-15N HSQC of 15N Migfilin LIM domains and Talin subdomains. 
Figure (a) shows the interaction between 15N Migfilin LIM 23 domain and unlabeled 
Talin head domain.  Spectrum (b) shows the interaction between Migfilin LIM 23 
domain and Talin F0F1 subdomains. Figure (c) shows the interaction between 
Migfilin LIM23 domains and Talin F0 domain. All spectra show significant chemical 
shift perturbation.    
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   (a)     (b) 
Figure 5.12. 1H-15N HSQC of 15N Talin subdomains and Migfilin LIM 
domains. Figure (a) shows the interaction between 15N Talin F0F1 and 
Migfilin LIM 23 domain. Spectrum (b) shows the interaction between Talin 
F0 and Migfilin LIM 23 domain. All spectra show significant chemical shift 
perturbation.    
 
abolished (Figure 5.13). These experiments heighten the effect of the His tag on LIM 
domain proteins. However, further analyses are necessary to validate our results.  
Although we have eliminated the possibility between the interaction of Talin H 
domain and Migfilin LIM domains, we questioned whether the rest of Migfilin, the 
proline rich region and/or the N-ter 1-85 residues may have an effect on Talin H binding. 
Migfilin 1-85 and 1-36 were kindly provided by Dr. Sujay Itchichanda. We performed 
2D HSQC experiments to evaluate our hypothesis.  
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   (a)      (b) 
Figure 5.13. 1H-15N HSQC of 15N Talin subdomains without the HIS tag 
and Migfilin LIM domains. Figure (a) shows the interaction  between 15N 
Talin F0F1(after cleavage of HIS tag) and Migfilin LIM 23 domain. 
Spectrum (b) shows the interaction between Talin F0 (after cleavage of HIS 
tag) and Migfilin LIM 23 domain. All spectra show no significant chemical 
shift perturbation.    
 
We analyzed the interactions of 15N Migfilin 1-86 - Talin F0F1/F1 and 15 N Talin 
F0/F0F1 – Migfilin 1-36mer by NMR-HSQC. We were not able to observe any 
significant chemical shift perturbations evidencing no interaction between Talin and 
Migfilin N-ter. An in vivo experiment performed by our collaborators showed a negative 
interaction between Migfilin proline rich region and Talin H.  
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5.3. Summary of chapter 5 results. 
NMR, SPR, ITC and in vivo assays have been used through out this thesis work, 
to understand the molecular role of Kindlin 2 in the process of integrin activation. Among 
the binding partners of Kindlin 2, the link between Kindlin 2 and Migfilin plays an 
indispensible role in integrin activation. To understand and validate the interaction 
between Kindlin 2 N-ter and Migfilin (obtained from in vivo assays), NMR was used as 
our primary method of analysis. 
To summarize, a very weak interaction was observed between Kindlin 2 full 
length/N-terminal 11-143 and Migfilin LIM domains. Continuing evidence from in vivo 
studies from our collaborators has strong support for the interaction between Kindlin 2 N-
ter and Migfilin. According to our schematic representation of integrin activation, the link 
between Migfilin and Kindlin play a crucial role in the establishment of the link between 
the actin cytoskeleton and the extracellular matrix.  
Integrin activation assays demonstrated the functional importance of both C and 
N terminal of Migfilin for integrin activation and deleting either of it would substantially 
diminish integrin activation. Our experiments have not recorded any interaction between 
Talin H domain and Migfilin full length protein. This eliminates our hypothesis on the 
formation of a ternary complex between Migfilin-Talin H-Kindlin 2 N-ter, which may 
help to stabilize activated integrin and enhance the effect of integrin activation.  
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CHAPTER VI  
 
KINDLIN C-TER AND INTEGRIN INTERACTION 
 
6.1. Introduction.  
Kindlin 2 C-term plays a significant role in integrin activation (Shi et al., 2007; 
Ma et al., 2008). A number of health related issues have been linked to the failure of C-
term Kindlin to interact with integrin CT. Thus, to investigating its role in integrin 
activation is becoming an area of interest. Up to date, there is no structural information 
available to evaluate the role of Kindlin proteins in integrin activation. Kindlin 2 F3 
subdomain and Talin F3 subdomain have similar homology. Through homology 
modeling, Ma et al. have mapped the interaction between Kindlin F3 and integrin CT 
(Shi et al., 2007; Ma et al., 2008; Bledzka et al., 2010). A structure based analysis of the 
interaction between Kindlin and integrin CT, would be necessary to understand and 
evaluate its mechanism in integrin activation. Up to date, there is no information 
available for the C-ter or full length structure of Kindlin. Lack of structural information 
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of Kindlin makes it difficult to evaluate the molecular role of Kindlin 2 C-ter in integrin 
activation. 
In order to evaluate and perceive an atomic level understanding of the interaction 
between Kindlin C-ter and integrin, we undertook an extensive analysis of Kindlin 2 C-
term. The next subchapter evaluates the attempt taken to obtain Kindlin 2 C-ter protein/s. 
 
6.2. Expression of Kindlin 2 C-terminal. 
To investigate the role of Kindlin 2 C-ter, obtaining the 3D structure of the 
protein is a necessity. As described in chapter 2, to initiate the process of recombinant 
protein expression, a prediction of the secondary structure of Kindlin 2 C-ter is helpful. In 
the process of cloning subdomain structures of Kindlin 2, the predicted secondary 
structural information would be beneficial in choosing the correct boundaries for the 
prospective protein (Appendix 1- Secondary structure prediction of Kindlin 2). 
The boundaries that have been chosen were selected within the coiled region of 
high probability without disturbing the predicted secondary structure. Several boundaries 
been chosen are: residues 565-658, 565-680, 485-680 and 567-662. Their fusion tag, 
bacterial strain, solubility etc are summarized in Table 4.2.  
All the constructs of the C-terminal F3 subdomain, have either no expression or a 
very low expression. The expressed protein is completely in the insoluble fraction of the 
cell. We reasoned that poor expression of F3 could be due to the presence of multiple rare 
codons in the sequence.  To evaluate this we expressed the protein in Rosetta 2 and RIP 
bacterial host strains, which are supplemented with additional plasmids for the expression 
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of rare tRNA codons in E.coli. A significant increase in the level of expression could not 
be seen even in Rosetta 2 bacterial host strain. 
The next approach was to obtain F2 subdomain of Kindlin 2. Although the C-
terminal F2 constructs have a higher level of expression, the expressed protein tends to be  
 
MIG-2  FUSION   BACTERIAL  PROTEIN            PROTEIN        GEL 
BOUNDARIES   TAG   HOST STRAIN EXPRESSION     SOLUBILTY    FILTRATION 
 
565-658  GST   BL21 (DE3) no expression   
MBP-HIS   BL21 (DE3) no expression  
    BL21 (DE3)pLys    no expression 
     Rosetta  (DE3)       no expression 
  Rosetta 2 (DE3) low expression in pellet 
 
567-662  HIS   Rosetta 2 low expression in pellet  
  GST   Rosetta 2 low expression in pellet    
567-665        HIS            Rosetta 2 low expression soluble             Aggregate 
567-680 
394-567  GST   Rosetta 2 low expression soluble             Aggregate 
 
 
Table 6.1. Summary of Kindlin 2 C-terminal constructs, their 
expression vectors, expression conditions and gel filtration data. 
 
a complete aggregate when subjected to size exclusion chromatography.  We reasoned, 
with evidence with the model structure, that F2 subdomain is packed against the potential 
PH domain and isolating F2 subdomain itself may expose hydrophobic residues/patches 
that might have initiated aggregation of F2. However, a construct including PH-F2 
domains did not substantially reduce the aggregation evidencing that the PH domain 
alone may not help the problem.  To understand whether aggregation is due to improper 
folding of the protein we assisted protein folding by introducing chaperones during 
protein expression. However, we were not able to observe any sort of an oligomeric state 
other than an aggregate when subjected to gel filtration. A close analysis of the sequence 
revealed multiple cysteine residues. We rationalized that intermolecular disulfide bond 
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formation may promote protein aggregation at an early stage of the protein purification 
process. A site directed mutation of C471A and C520S of Kindlin 2 459-567 construct of 
F2 subdomain did not prevent aggregation at all. To further reason out the effect of buffer 
interferences we performed the purification process in multiple buffers. PBS buffer at pH 
7.0 was used for most protein purification protocols. We change the buffer to MES at pH 
6.4 and Tris-HCl at pH 8.0. Results showed that change in buffer did not help in 
preventing or reducing the fact that the protein is aggregating. As an additional step we 
reasoned that protein stabilizing agents like cryotropes, kosmotropes, detergents etc may 
help to prevent aggregation when added throughout the protein purification process. I 
performed an aggregation assay (Saunders et el., 2008) using a wide variety of buffer 
additives. None of the additives helped except 1% sarkosyl. Sarkosyl is a very strong 
detergent, which is known to rupture the tertiary structure of the protein. Since sarkosyl 
helped partially to prevent/reduce aggregation we think that aggregation is initiated 
through hydrophobic contacts. We are limited by choosing additives because of NMR 
compatibility. None of the approaches helped so far to shift the Kindlin 2 F2 domain 
protein from being an aggregate to a lower order oligomer or monomer. 
To summarize, we have cloned Kindlin 2 C-ter extensively. However we were not 
able to obtain any subdomain protein due to various difficulties in expression and 
aggregation of the protein.  
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6.3.Summary of chapter 6 results 
The attempts of obtaining the C-terminal subdomain protein of Kindlin 2 failed 
due to varying degrees of difficulties in expression constructs. Certain approaches are 
outlined in chapter v, which could be useful in future to guide through to obtain Kindlin 2 
C-ter protein for prospective functional analyses.   
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CHAPTER VII 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
This thesis work has been concerned with understanding the role of Kindlin 2 in 
integrin activation. Our primary focus is to understand the function of Kindlin 2 in a 
structural point of view, which will give us more insight to understand the mechanism of 
Kindlin 2 at atomic level. Initial trials of full length Kindlin 2 protein expression were 
low and we were not able to obtain sufficient amounts for structural analyses. However, 
we were able to obtain subdomain proteins of Kindlin 2 after extensive subcloning. 
Currently, we have Kindlin 2 F0 domain (residues 1-105 and 11-143), Kindlin 2 F1 
fragment (residues 155-268 and 143-154 peptide) and Kindlin 2 PH domain. The F0 
domain is a high yielding and stable protein suitable for NMR studies. We have obtained 
the structure of Kindlin 2 F0 domain through solution NMR.  Kindlin 2 155-268 is a 
tetramer and NMR structure determination would not be feasible. However, X-ray 
crystallography could be the method of choice for Kindlin 2 155-268 structure.   
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Kindlin 1 and 2 F0 domains have a similar beta grasp fold. The structures show minor but 
distinct differences that lead us consider with the possibilities of functional differences 
between Kindlin 1 and 2 F0 domains. Thus evolutionary, the structural differences in the 
F0 domains may have developed for potential functional differences. There are no facts 
in literature that show functional differences between the F0 domains. As a future step it 
would be interested to investigate whether these minor differences in structure may 
impose significant differences in their function.  
 
A remarkable finding during this thesis work is that Kindlin 2 F0 domain plays a 
fundamental role in integrin activation. Deletion of F0 domain from full length Kindlin 2 
substantially reduced integrin activation (due to PAC1 binding) in comparison to full 
length Kindlin 2. One goal of this thesis was to understand how Kindlin 2 F0 contributes 
in the integrin activation mechanism i.e. to find the structural determinants of Kindlin F0 
domain and understand its central role in integrin activation. We have observed a weak 
interaction of the F0 domain with the membrane, PIP3 and integrin β3 CT membrane 
proximal residues and a 1µM affinity of PH and PIP3. All these data show that F0 and 
PH domains of Kindlin 2 interact with the membrane surface. Based on our and our 
collaborators data we proposed that Kindlin F0 and PH domain tether to the membrane to 
enhance the effect of Kindlin 2 in integrin activation (Figure 7.1.). 
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Figure 7.1. Schematic diagram of the proposed model of integrin 
activation. This shows that integrin CT is associated with Filamin through 
multiple binding sites and maintains integrin at the resting state or inactive 
state. Upon activation, Talin binds to the membrane proximal β3 CT, 
Kindlin is tethered to the membrane via the PH domain and facilitates the 
interaction between Kindlin C-ter F3 and integrin CT. 
 
A closer look at the N-terminal sequence of Kindlin 2 shows a stretch of multiple 
positive charges encompassing the nuclear localization signal between the PH domain 
and F0 domain. There is a possibility, that these positive charges on Kindlin 2 may help 
the full length protein to anchor to the negatively charged membrane surface. This may 
further strengthen our hypothesis, where multiple domains of Kindlin 2 or in part may 
interact with the membrane surface essentially to tether Kindlin 2 to the membrane to 
facilitate the effect of Kindlin 2 in integrin activation. A future direction to validate our 
hypothesis is a thorough analysis using structure based mutagenesis and functional 
assays. Papayannopoulos et al. have shown that a polybasic motif in N-WASP directly 
binds to PIP2 and regulates its activity (Papayannopoulos et al., 2003).  There is a 
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possibility that the polybasic motif of Kindlin 2 may also has some regulatory 
significance. It would be interesting to analyze whether this poly basic stretch of residues 
in Kindlin 2 play a role in membrane anchoring or has a regulatory function.  
According to our data and literature, both F0 domain and F3 domain of Kindlin 2 
and Talin F3 domain interact with the integrin β3 CT. It is quite interesting how all these 
proteins may bind to the ~50 amino acid length β3 cytoplasmic tail of integrin. Observing 
the model structures of Kindlin 2, it is clear that Kindlin 2 N-ter F0 and C-ter F3 domains 
are spatially close. In a 3D space, it is possible that all above mentioned domains have 
contact with the β3 CT.    
The binding sites on Kindlin 2 F0 domain structure, due to integrin interaction in 
blue and membrane interaction in magenta is shown below. It is clear from figure 7.2. 
that the interaction sites are not overlapping. This supports our hypothesis that Kindlin F0  
domain interacts with the membrane and partly facilitates the effect of Kindlin 2 in 
integrin activation.  
               
                 (a)                                             (b)                                        (c) 
Figure 7.2. Kindlin 2 F0 dmain structure.  Highlighted residues are due 
to integrin interaction (partly) in blue and PIP/membrane interaction in 
magenta. (a) Ribbon diagram (b) surface view (c) surface view after 180 
deg rotation from (b). 
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Another aspect in this multi-collaborative-project is to understand the significance 
of Migfilin and Kindlin 2 interaction. Among the binding partners of Kindlin 2, the 
interaction between Kindlin N-ter and Migfilin plays an indispensible role in recruiting 
Migfilin to focal adhesion (Tu et al., 2003). To validate the interaction obtained from in 
vivo assays and understand the interaction specifics between Kindlin 2 N-ter and 
Migfilin, NMR was used as our primary method of analysis. 
Our results show an interaction between Kindlin 2 11-143 residues with Migfilin 
LIM23 domains. However, further truncation of the protein abolished the interaction 
between Kindlin and Migfilin. We postulate that the F1 subdomain (F1 fragment), which 
is C terminally located from the F0 domain, may impose an effect on the core F0 domain 
structure and facilitates the interaction with Migfilin LIM domains. Evidence from our 
collaborators has reported a positive interaction between the Kindlin 2 N-ter 1-218 and 
Migfilin LIM domains. The facts that:  
1. We only observed an interaction between Kindlin 2 11-143 and Migfilin LIM 
domains although we screened all fragments of Kindlin 2 1-268 protein in vitro. 
2. Truncation of Kindlin 2 11-143 abolished the interaction with Lim domains in 
vitro. 
3. A larger fragment of 1-218 show a positive interaction in vivo  
supports our hypothesis of a 3D functional structure, which is distorted during truncation 
of larger a fragment into smaller sub-domain proteins of Kindlin 2. 
All model structures of Kindlin 2 show that the F0 and F1 fragments (highlighted in 
yellow and red) residues 1-276 form a well defined core structure (see below). The core 
(shown by an arrowhead) is surrounded by localized positive and negative charges. It is 
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possible that this structure is the functional structure that mediates Migfilin LIM domain 
interaction. Truncation may distort the functional structure and abolish interaction, which 
is consistent with our data.  
                                           
Figure 7.3. Part of the full length Kindlin 2 Model 1 highlighting F0 
domain in blue and F1 fragments in yellow and red.  
 
An expression construct made for Kindlin 2 1-276 had no significant protein 
expression. We were able to obtain F0 (blue) and 155-268 residues (red and part of 
yellow) separately. Expression constructs with incorporation of the positive charges, 
Kindlin 2 1-154, 1-177, 11-158, are either insoluble or are soluble aggregates. If the 
interaction between Migfilin and Kindlin 2 is mediated via the F0-F1 core structure, 
obtaining the protein would be a necessary step.   
Model structures of Kindlin 2 display that the F0 subdomain of Kindlin 2 holds a 
central position in the structure. It forms a core structure together with F1 subdomain 
fragments on one side and is in close contact with other domains in the structure. This 
positioning of F0 domain may stabilize all interacting domains of the structure. There is a 
possibility that deleting F0 domain from the full length protein may perturb the 3D 
structure.  This may influence the interaction/association with integrin and other proteins 
+ 
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like Migfilin. The integrin activation assay shown in figure 4.1. in chapter 4 shows that 
deletion of the F0 domain from the full length Kindlin 2 abolish integrin activation, 
demonstrating the central role of Kindlin 2 F0 domain. In order to understand the position 
of the F0 domain in the full length protein, the 3D structure of Kindlin 2 is necessary. 
 
Kindlin 2 is a phosphor protein where residues 159 and 181 are phosphorylated.  
In vivo assays have demonstrated a positive interaction for Kindlin 2 1-218. The two 
potential phosphorylation sites are located within 1-218 residues. Kindlin 2 for in vivo 
analysis was purified from mammalian cells and for in vitro analysis from bacterial 
expression systems. Bacteria lack the bio mechanism for many types of post-translational 
modifications. If a post-translational modification such as a phosphorylation is necessary 
for the interaction between Kindlin 2 and Migfilin, in vitro experiments would not detect 
the interaction. There are many examples in literature to support this kind of 
phenomenon. One example is the interaction between the integrin cytoplasmic tail and 
Dok1 protein. Dok1 is cytoplasmic protein and is involved in many signaling pathways.  
It also plays an important role in cell migration (Yamanashi et el, Cell 1997; Noguchi et 
el, EMBO J 1999). Both Talin PTB and Dok1 PTB domains binds to the central NPxY747  
motif of the β3 integrin CT. The major difference of this interaction is that Dok1 
negatively regulate integrin activation and Talin activates integrin (Wegener, K.L. et el, 
cell 2007). This contrasting role of function occurs due to one simple modification in the 
sequence. Phosphorylation of Tyr747 residue shows a dramatic change in binding 
affinities. Another more recent example explains that Kindlin 2 PTB domain itself shows 
a higher affinity for non-phosporylated Y759 on integrin CT than the phophorylated tail 
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(Bledzka et al., 2010). There are many types of post-translational modifications that can 
occur in mammalian cells and not found in bacterial cell machineries. Phosphorylation is 
one such mechanism that change or control the behavior of the protein. Kindlin and 
Migfilin are relatively large proteins with multiple phosphorylation sites. So the only way 
to incorporate potential PTM is to grow the protein in a mammalian expression system, 
insect cell expression systems or the more common baculovirus insect cell expression 
system.  
Although an interaction between Kindlin 2 N-term and Migfilin LIM domains 
was observed in biological assays, we were not able to pin down the exact binding 
interface/s using in-vitro studies (NMR, SPR and ITC experiments). As described above, 
the possibilities of (1) a distortion in the function 3D structure through subcloning, (2) a 
post-translational modification at the binding surface in Kindlin or Migfilin (3) a central 
role of F0 domain in the full length protein could be reasoned, and investigating and 
evaluating these possibilities would be a future necessary step for the molecular level 
understanding of the role of Kindlin and Migfilin in integrin activation. 
The interaction between Kindlin 2 and Migfilin plays a significant role in cell 
adhesion processes. In addition to the structural role in the cell by forming a connection 
via the ECM and actin cytoskeleton, Kindlin-2 and Migfilin have become essential 
elements in the process of integrin activation. Our data on integrin activation assays in 
figures Fig 5.9 and 5.10 have emphasized the significance of both Kindlin and Migfilin in 
Talin induced integrin activation. How does Migfilin contribute to enhance integrin 
activation? Our hypothesis of the formation of a ternary complex via Migfilin-Kindlin N-
ter-Talin H interactions would stabilize the interaction with integrin CT thereby 
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heightening the effect of activated integrins was evaluated giving particular interest to 
Migfilin and Talin H interaction. Our data have eliminated the possibility of this 
interaction using NMR.  How does Migfilin overexpression enhance the effect of integrin 
activation? From literature it is evident that Migfilin N-ter removes the negative 
regulatory effect of Filamin from the integrin CT. Kindlin 2 and Migfilin interaction 
recruits Migfilin to the focal adhesion site allowing Migfilin N-ter to interact with 
Filamin. Further analyses are necessary to evaluate and understand the cooperate role of 
Migfilin/Kindlin/TalinH in integrin activation. 
 
The role of Kindlin C-term F3 domain in Talin induced integrin activation has 
been demonstrated in literature. However, up-to-date there are no structural studies on 
Kindlin 2 C term been reported. As a goal of this thesis work, we have been extensively 
subcloning and optimizing the C-term Kindlin 2 in order to obtain a soluble protein for 
structure based analysis. Despite the varying number of bacterial expression systems, 
vectors, fusion tags, mutations, optimization strategies, we were not able to obtain a 
soluble monomeric protein for the C-term of Kindlin 2. For the molecular level 
understanding of integrin activation, the structure of Kindlin is a necessary component. In 
future work, it is beneficial to further subclone changing the boundaries of the protein in 
the scope of obtaining a suitable protein. As an immediate future step, subcloning from 
lower species like mouse and C. elegans would be helpful. The mouse and human 
Kindlin 2 amino acid sequences have a 98% similarity while the DNA sequences show 
87% homology.  Obtaining the Kindlin 2 C-term protein will allow us to evaluate the 
interaction between Kindlin C-term and integrin and investigate the prospective auto 
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inhibitory mechanism.  Certain approaches outlined here, could be useful in future to 
guide to obtain Kindlin 2 C-ter protein for prospective functional analyses.   
Modeling studies suggest that there is a possible interaction between the N-ter and 
FERM domain of Kindlin 2. A similar interaction is seen in Talin. (Goksoy et al., 2008). 
Talin rod domain and PTB domain interaction keeps Talin in its inactive dimeric 
conformation. PIP2 disrupts the binding interface between the rod domain and PTB 
domain and opens up the binding interface for integrin activation. Having similar 
structural architecture and binding patterns, we assume that similar to Talin, Kindlin 
obtains an inactive conformation through N-ter and C-ter interaction. In vivo data from 
on-going studies have clearly shown that Kindlin 2 interacts with PIP3. Based on this 
data we further hypothesize that the active conformation is revealed through potent PIP3 
interaction.  
In addition to Talin, N-WASP, an actin polymerization protein, is another protein 
where the C-ter and N-term interaction is disrupted by potent PIP2 and Cdc42 binding. 
PIP2 binds to a polybasic stretch in the sequence which perturbs the C and N terminal 
interaction thereby revealing the active form of N-WASP (Venizelos Papayannopoulos et 
el, 2007, Molecular cell). A similar sequence motif of positively charged residues is 
found in Kindlin 2, residues 148-154. The fact hat modeling structures suggest that there 
is a Kindlin C-ter and N-ter interaction and PIP3 disrupts the interaction may support our 
hypothesis on the proposed autoinhibition mechanism for Kindlin 2. Obtaining the C-
terminal protein will be first step to conduct a detailed analysis in order to support the 
prospective auto-inhibitory mechanism of Kindlin 2.  
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To conclude, Kindlins play an indispensable role in integrin activation. The role 
of Kindlin 2 C-ter has been determined (Ma, Yang-Qing et al., 2008). However, up-to-
date there is a lack of information in literature about the role of the N-ter domains of 
Kindlin 2. Here we have elucidated certain interacting partners of Kindlin 2 N-ter and 
hypothesized its role in integrin activation. In brief, we have solved the structure of the 
F0 domain of Kindlin 2 and have elucidated specific non-overlapping binding sites on F0 
due to integrin β3 and PIP3 binding. In support with other in vivo and in vitro data, we 
hypothesized that the Kindlin 2 N-terminal domain/s interacts with the membrane and 
helps the full length Kindlin 2 protein to anchor to the membrane surface. This 
interaction may stabilize Kindlin 2 and helps to facilitate the effect of Kindlin 2 in 
integrin activation.  In addition, we have elucidated that the F0 domain has partially 
overlapping binding sites with the membrane and Migfilin LIM domains. Kindlin 2 F0 
deletion constructs completely abolishes integrin activation, further heightening the 
significance of Kindlin 2 F0 domain. Overall, this work has given a better understanding 
of the of Kindlin 2 N-ter.  
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APPENDIX 1 
 
 
Kindlin 2 Full Length human PSIPRED PREDICTION RESULTS 
 
 
Conf: Confidence (0=low, 9=high) 
Pred: Predicted secondary structure (H=helix, E=strand, C=coil) 
AA: Target sequence 
 
     
# PSIPRED HFORMAT (PSIPRED V2.5 by David Jones) 
 
 
 
Conf: 973631256777403402368996278854799998145147999999988768543221 
Pred: CCCCCEECCCCCEECCEEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHCCCCCCCC 
  AA: MALDGIRMPDGCYADGTWELSVHVTDVNRDVTLRVTGEVHIGGVMLKLVEKLDVKKDWSD 
              10        20        30        40        50        60 
 
Conf: 000218534033531112353012326330113357616998599977899974270079 
Pred: CCCCHHHHCCHHHHHHHHHHHCCCCCCCCCCCCCCCCEEEEECCCCCEEEEEEECCCHHH 
  AA: HALWWEKKRTWLLKTHWTLDKYGIQADAKLQFTPQHKLLRLQLPNMKYVKVKVNFSDRVF 
              70        80        90       100       110       120 
 
Conf: 999998888087871000123578551332102464323432101688745778877565 
Pred: HHHHHHHHHCCCCCCHHHCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCC 
  AA: KAVSDICKTFNIRHPEELSLLKKPRDPTKKKKKKLDDQSEDEALELEGPLITPGSGSIYS 
             130       140       150       160       170       180 
 
Conf: 888876767866666788746776545677532456776324589988855753146726 
Pred: CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCH 
  AA: SPGLYSKTMTPTYDAHDGSPLSPTSAWFGDSALSEGNPGILAVSQPITSPEILAKMFKPQ 
             190       200       210       220       230       240 
 
Conf: 688987323576787840120686999789999802245124888672553101245565 
Pred: HHHHHHHCCCCCCCCCCCHHHCCCCCCCEEEEEEECEEEECCCCCCCCEEEEEHHHHHHH 
  AA: ALLDKAKINQGWLDSSRSLMEQDVKENEALLLRFKYYSFFDLNPKYDAIRINQLYEQAKW 
             250       260       270       280       290       300 
 
Conf: 663488556899998860300112102456776777666610343787500121670178 
Pred: HHHCCCCCCCHHHHHHHHHHEEEEECCCCCCCCCCCCCCCCHHHHHHHHHCCCEEEECCC 
  AA: AILLEEIECTEEEMMMFAALQYHINKLSIMTSENHLNNSDKEVDEVDAALSDLEITLEGG 
             310       320       330       340       350       360 
 
Conf: 767520022000766320100152122334430368999706365430732327572334 
Pred: CCCCCCHHHHCCHHHHCCCHHCCCCCCCCCCCEEEEEEEECCEEEEEECHHHCCCCCHHH 
  AA: KTSTILGDITSIPELADYIKVFKPKKLTLKGYKQYWCTFKDTSISCYKSKEESSGTPAHH 
             370       380       390       400       410       420 
 
Conf: 156762451010004662017998304898426999448756688787750333165300 
Pred: CCCCCCEEECCCCCCCCCEEEEEEECCCCCCEEEEEECCCHHHHHHHHHHHHHHHCCCCC 
  AA: MNLRGCEVTPDVNISGQKFNIKLLIPVAEGMNEIWLRCDNEKQYAHWMAACRLASKGKTM 
             430       440       450       460       470       480 
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Conf: 012205899999999971699987432731246677820034378828875002468999 
Pred: CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHH 
  AA: ADSSYNLEVQNILSFLKMQHLNPDPQLIPEQITTDITPECLVSPRYLKKYKNKQITARIL 
             490       500       510       520       530       540 
 
Conf: 975442288999999999999874500041189998508886339999331412126357 
Pred: HHHHHHCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCCCEEEEECHHHEEEECCCC 
  AA: EAHQNVAQMSLIEAKMRFIQAWQSLPEFGITHFIARFQGGKKEELIGIAYNRLIRMDAST 
             550       560       570       580       590       600 
 
Conf: 977899861200013258985499985167531789999478132477877779888256 
Pred: CCEEEEEECCCCCCCCCCCCCEEEEEECCCCCCEEEEEEECCCHHHHHHHHHHHHHHHCC 
  AA: GDAIKTWRFSNMKQWNVNWEIKMVTVEFADEVRLSFICTEVDCKVVHEFIGGYIFLSTRA 
             610       620       630       640       650       660 
 
Conf: 01057300888777415769 
Pred: HHHCCCCHHHHHHHHCCCCC 
  AA: KDQNESLDEEMFYKLTSGWV 
             670       680 
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APPENDIX 2. 
 
Talin and PIP interaction studies. 
 
Activation of integrin heterodynamic receptors is essential for ligand binding and 
subsequent cellular signaling and cellular processes. Talin H domain has been identified 
as the key molecule in integrin activation. It has been reported that Talin full length 
protein has substantially less affect on integrin activation compared to Talin H domain. 
Goksoy et el have shown through NMR analysis that there is an interaction between the 
Talin rod domain and Talin H domain that holds Talin in its inactivate conformation, 
inability to interact with integrin CT and subsequent activation. More precisely the Talin 
PTB domain (F3 sub-domain) which binds to integrin CT, is masked by Talin rod 
domain. The interaction between Talin rod domain and H domain is disrupted by PIP2 
interaction or by a M319A mutation. Part of this interaction work was published at 
Goksoy, E., Ma, Y.Q., Wang, X., Kong, X., Perera, D., Plow, E.F., and Qin, J. (2008). 
Structural basis for the autoinhibition of talin in regulating integrin activation. Mol. Cell 
31, 124-133.  
 
NMR titration curve: Binding Interaction between Talin F3 subdomain and PIP2  
In order to understand the chemical shift perturbation of Talin F3 upon PIP2 
binding we performed an NMR titration experiment. The HSQC spectra were recorded 
with of Talin F3 and PIP2(C4)/PIP2(C8) at increasing molar ratios. The Overlaying 
HSQC spectra of Talin F3 and PIP2(C8) is shown in figure 1. The protein completely 
precipitated after 1:1 molar ration of F3 and PIP2(C8). Talin F3 and PIP2(C4) was a 
much stable complex. Thus the NMR titration experiment was performed with PIP2(C4). 
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The peak perturbation was recorded for all peaks of Talin F3, upon addition of 1:0.2, 
1:0.4 1: 0.6,…1:3.25 of PIP2(C4) molar ratios. The chemical shift perturbation profile of 
Talin F3 is shown below. The corresponding total chemical shift perturbation table for 
1:3.25 molar ratio of Talin F3 vs. PIP2(C4) is shown below.   
 
Figure 1. Appendix 2. Overlay of 1H-15N HSQC spectra of Talin F3 and 
PIP2C8) titration. Black- HSQC Talin F3 free, green-Talin F3 and PIP2 at 
1:0.25, red - 1:0.5 and purple - 1:0.75 molar ratios.  
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Chemical shift perturbation map Talin F3 vs. PIP2(C4)
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Figure 2. Appendix 2. Chemical shift perturbation profile of all residue 
of Talin F3 (309-405). 
 
 
 
Chemical Shift Purtabations at 1: 3.25 molar ratio for talin F3 vs PIP2C4 titration 
Res 
                    
free form complex       
N H N H ∆Ν ∆Η 0.154∗∆Ν (0.154∗∆Ν)2 ∆Η2 δ 
           
309 
         0.0000 
310 120.82 7.71 120.85 7.73 0.03 0.00 0.00462 0.00002 0.00000 0.0042 
311 123.27 8.09 123.30 8.12 0.03 
-
0.01 0.00462 0.00002 0.00010 0.0110 
312 122.65 8.56 122.66 8.57 0.01 0.01 0.00154 0.00000 0.00010 0.0101 
313 120.01 9.18 120.03 9.20 0.02 0.00 0.00308 0.00001 0.00000 0.0031 
314 127.28 9.43 127.31 9.45 0.03 0.00 0.00462 0.00002 0.00000 0.0046 
315 123.84 9.34 123.83 9.36 
-
0.01 0.00 -0.00154 0.00000 0.00000 0.0015 
316 116.50 8.37 116.51 8.38 0.01 0.01 0.00154 0.00000 0.00010 0.0101 
317 123.11 9.20 123.10 9.22 
-
0.01 0.00 -0.00154 0.00000 0.00000 0.0015 
318 124.47 8.95 124.44 8.98 
-
0.03 
-
0.01 -0.00462 0.00002 0.00010 0.0110 
319 127.02 8.94 126.89 8.94 
-
0.13 0.02 -0.02002 0.00040 0.00040 0.0283 
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320 125.17 8.62 125.13 8.63 
-
0.04 0.01 -0.00616 0.00004 0.00010 0.0117 
321 
          
322 118.64 7.72 118.64 7.76 0.00 
-
0.02 0.00000 0.00000 0.00040 0.0200 
323 
          
324 119.45 7.45 119.42 7.48 
-
0.03 
-
0.01 -0.00462 0.00002 0.00010 0.0110 
325 124.16 8.49 124.15 8.50 
-
0.01 0.01 -0.00154 0.00000 0.00010 0.0101 
326 121.64 9.31 121.72 9.30 0.08 0.03 0.01232 0.00015 0.00090 0.0324 
327 
          
328 123.20 9.13 123.21 9.14 0.01 0.01 0.00154 0.00000 0.00010 0.0101 
329 121.67 8.35 121.67 8.37 0.00 0.00 0.00000 0.00000 0.00000 0.0000 
330 126.72 9.71 126.73 9.72 0.01 0.01 0.00154 0.00000 0.00010 0.0101 
331 113.25 9.79 113.27 9.81 0.02 0.00 0.00308 0.00001 0.00000 0.0031 
332 124.16 8.94 124.04 8.96 
-
0.12 0.00 -0.01848 0.00034 0.00000 0.0185 
333 121.64 9.31 121.72 9.30 0.08 0.03 0.01232 0.00015 0.00090 0.0324 
334 112.01 7.86 112.04 7.89 0.03 
-
0.01 0.00462 0.00002 0.00010 0.0110 
335 111.70 7.71 111.73 7.73 0.03 0.00 0.00462 0.00002 0.00000 0.0046 
336 118.44 8.10 118.47 8.11 0.03 0.01 0.00462 0.00002 0.00010 0.0110 
337 118.11 8.95 118.12 8.96 0.01 0.01 0.00154 0.00000 0.00010 0.0101 
338 122.89 9.78 122.91 9.81 0.02 
-
0.01 0.00308 0.00001 0.00010 0.0105 
339 122.74 8.77 122.79 8.80 0.05 
-
0.01 0.00770 0.00006 0.00010 0.0126 
340 126.20 9.40 126.25 9.42 0.05 0.00 0.00770 0.00006 0.00000 0.0077 
341 127.82 8.69 127.84 8.71 0.02 0.00 0.00308 0.00001 0.00000 0.0031 
342 128.61 9.22 128.64 9.24 0.03 0.00 0.00462 0.00002 0.00000 0.0046 
343 117.77 8.48 117.77 8.49 0.00 0.01 0.00000 0.00000 0.00010 0.0100 
344 108.80 8.45 108.80 8.46 0.00 0.01 0.00000 0.00000 0.00010 0.0100 
345 114.98 7.95 114.99 7.97 0.01 0.00 0.00154 0.00000 0.00000 0.0015 
346 118.98 7.63 118.98 7.64 0.00 0.01 0.00000 0.00000 0.00010 0.0100 
347 124.87 8.78 124.86 8.80 
-
0.01 0.00 -0.00154 0.00000 0.00000 0.0015 
348 129.30 9.01 129.33 9.02 0.03 0.01 0.00462 0.00002 0.00010 0.0110 
349 118.11 7.40 118.11 7.42 0.00 0.00 0.00000 0.00000 0.00000 0.0000 
350 124.40 8.16 124.37 8.18 
-
0.03 0.00 -0.00462 0.00002 0.00000 0.0046 
351 123.84 9.34 123.83 9.36 
-
0.01 0.00 -0.00154 0.00000 0.00000 0.0015 
352 116.95 8.72 116.96 8.73 0.01 0.01 0.00154 0.00000 0.00010 0.0101 
353 126.63 8.38 126.64 8.40 0.01 0.00 0.00154 0.00000 0.00000 0.0015 
354 105.85 7.86 105.84 7.88 
-
0.01 0.00 -0.00154 0.00000 0.00000 0.0015 
355 118.31 7.80 118.32 7.82 0.01 0.00 0.00154 0.00000 0.00000 0.0015 
356 119.48 7.32 119.72 7.33 0.24 0.01 0.03696 0.00137 0.00010 0.0383 
357 128.19 8.99 128.31 9.03 0.12 
-
0.02 0.01848 0.00034 0.00040 0.0272 
358 115.00 7.90 114.77 7.92 
-
0.23 0.00 -0.03542 0.00125 0.00000 0.0354 
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359 117.89 7.36 117.72 7.38 
-
0.17 0.00 -0.02618 0.00069 0.00000 0.0262 
360 
          
361 124.93 9.02 124.91 9.03 
-
0.02 0.01 -0.00308 0.00001 0.00010 0.0105 
362 120.92 8.97 121.05 9.00 0.13 
-
0.01 0.02002 0.00040 0.00010 0.0224 
363 
          
364 111.18 7.79 111.24 7.83 0.06 
-
0.02 0.00924 0.00009 0.00040 0.0220 
365 114.97 7.76 115.07 7.78 0.10 0.00 0.01540 0.00024 0.00000 0.0154 
366 119.67 8.66 119.68 8.68 0.01 0.00 0.00154 0.00000 0.00000 0.0015 
367 122.84 8.01 122.84 8.05 0.00 
-
0.02 0.00000 0.00000 0.00040 0.0200 
368 124.16 8.94 124.04 8.96 
-
0.12 0.00 -0.01848 0.00034 0.00000 0.0185 
369 120.37 7.93 120.30 7.92 
-
0.07 0.03 -0.01078 0.00012 0.00090 0.0319 
370 124.16 8.90 124.15 8.89 
-
0.01 0.03 -0.00154 0.00000 0.00090 0.0300 
371 110.35 9.02 110.49 9.07 0.14 
-
0.03 0.02156 0.00046 0.00090 0.0369 
372 121.79 8.45 121.98 8.49 0.19 
-
0.02 0.02926 0.00086 0.00040 0.0354 
373 120.27 8.12 120.25 8.16 
-
0.02 
-
0.02 -0.00308 0.00001 0.00040 0.0202 
374 118.94 8.14 118.6 8.09 
-
0.32 0.07 -0.04959 0.00246 0.00449 0.0834 
375 119.75 8.30 119.96 8.32 0.21 0.00 0.03234 0.00105 0.00000 0.0323 
376 109.40 8.11 109.68 8.13 0.28 0.00 0.04312 0.00186 0.00000 0.0431 
377 120.11 7.90 120.21 7.95 0.10 
-
0.03 0.01540 0.00024 0.00090 0.0337 
378 124.89 8.72 124.62 8.72 
-
0.27 0.02 -0.04158 0.00173 0.00040 0.0461 
379 122.16 8.28 122.25 8.31 0.09 
-
0.01 0.01386 0.00019 0.00010 0.0171 
380 117.02 8.82 116.95 8.84 
-
0.07 0.00 -0.01078 0.00012 0.00000 0.0108 
381 120.82 9.07 120.90 9.13 0.08 
-
0.04 0.01232 0.00015 0.00160 0.0419 
382 120.60 7.86 120.67 7.89 0.07 
-
0.01 0.01078 0.00012 0.00010 0.0147 
383 118.06 8.73 118.06 8.75 0.00 0.00 0.00000 0.00000 0.00000 0.0000 
384 124.24 9.16 124.28 9.19 0.04 
-
0.01 0.00616 0.00004 0.00010 0.0117 
385 110.65 9.27 110.70 9.29 0.05 0.00 0.00770 0.00006 0.00000 0.0077 
386 119.48 7.32 119.72 7.33 0.24 0.01 0.03696 0.00137 0.00010 0.0383 
387 119.58 7.52 119.58 7.54 0.00 0.00 0.00000 0.00000 0.00000 0.0000 
388 121.53 7.54 121.57 7.56 0.04 0.00 0.00616 0.00004 0.00000 0.0062 
389 119.50 8.15 119.52 8.16 0.02 0.01 0.00308 0.00001 0.00010 0.0105 
390 115.18 7.61 115.18 7.62 0.00 0.01 0.00000 0.00000 0.00010 0.0100 
391 121.59 7.34 121.61 7.36 0.02 0.00 0.00308 0.00001 0.00000 0.0031 
392 117.65 7.81 117.66 7.83 0.01 0.00 0.00154 0.00000 0.00000 0.0015 
393 120.53 8.34 120.51 8.37 - - -0.00308 0.00001 0.00010 0.0105 
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0.02 0.01 
394 104.05 7.61 104.07 7.63 0.02 0.00 0.00308 0.00001 0.00000 0.0031 
395 121.74 7.74 121.75 7.76 0.01 0.00 0.00154 0.00000 0.00000 0.0015 
396 123.02 8.84 123.02 8.86 0.00 0.00 0.00000 0.00000 0.00000 0.0000 
397 120.08 7.96 120.21 7.95 0.13 0.03 0.02002 0.00040 0.00090 0.0361 
398 116.69 7.28 116.71 7.30 0.02 0.00 0.00308 0.00001 0.00000 0.0031 
399 121.47 7.59 121.47 7.61 0.00 0.00 0.00000 0.00000 0.00000 0.0000 
400 119.53 8.50 119.55 8.52 0.02 0.00 0.00308 0.00001 0.00000 0.0031 
401 118.49 7.87 118.51 7.89 0.02 0.00 0.00308 0.00001 0.00000 0.0031 
402 119.60 7.77 119.62 7.79 0.02 0.00 0.00308 0.00001 0.00000 0.0031 
403 121.21 7.95 121.22 7.96 0.01 0.01 0.00154 0.00000 0.00010 0.0101 
404 123.12 8.24 123.12 8.26 0.00 0.00 0.00000 0.00000 0.00000 0.0000 
405 122.84 7.93 122.84 7.95 0.00 0.00 0.00000 0.00000 0.00000 0.0000 
 
Table 1. Appendix 2. Chemical shift perturbation table for Talin F3 
and PIP2(C4) interaction.  δ=[0.154∗∆Ν2+∆H2]1/2 
 
 
ITC experiment: Interaction between Talin Rod domain and Talin head domain 
Talin is a 270KDa protein. As explained above, understanding the interaction 
between Talin H domain 50KDa and Rod domain 220KDa through NMR is difficult as it 
exceeds the size limitation for NMR which is 40KDa. As an alternative method we used 
ITC to understand the interaction.  
ITC has no limitation in size for analysis. The method was explained in chapter 2. 
It provides a complete thermodynamic profile of the binding interaction.  
We have performed an ITC experiment between Talin H and rod domain. A 
50µM solution of Talin Rod domain was used in the sample cell and titrated against 1.0 
mM solution of Talin head domain. The ITC titration curve is shown in the figure 3 
below.  The binding affinity between talin H and rod domain is 10µM.  
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Figure 3. Appendix 2. ITC titration curve for Talin Head domain and 
Talin Rod domain interaction.  
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ITC experiment: Talin H, F3, F2F3 domain and PIP2 interaction 
 
These experiments were performed to understand the interaction between Talin H domain 
and PIP2.    
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Figure 4. Appendix 2. ITC titration curve for Talin F3 domain and 
PIP2(C4). Talin F3 domain and PIP2(C4) shows a weak interaction.  
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Figure 5. Appendix 2. ITC titration curve for Talin F2F3 domain and 
PIP2(C6).  
The ITC experiment of Talin F2F3 and PIP2(C6) interaction is shown in 
figure 5. There was a continuous drift in the baseline during the experiment. 
We are not able to calculate the thermodynamic profile of the binding 
interaction due to the drift. However it is interesting to note, that the titration 
between F2F3 and PIP2(C6) starts with an exothermic reaction, switches to 
an endothermic reaction half way through the titration and finally saturates 
at the last 4 injections. These types of interactions are an indication of a 1:2 
molar ratio binding.     
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Figure 6. Appendix 2. ITC Titration curve for Talin H domain and 
PIP2(C6).  
The ITC titration between Talin H domain and PIP2(C6) is shown in figure 6. The 
data did fit into a 2 site binding interaction model indicating a 1:2 molar ratio 
binding event. This is consistent with figure 5, F2F3 and Talin PIP2(C6) interaction 
of a 1:2 molar ration interaction.  
Our data of two site binding sites for PIP2 on F2F3 is consistent with: a recently 
published paper and ongoing studies, where the two binding sites for PIP are on F2 
and F3 sub-domains respectively (Saltel et al., 2009).  
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NMR experiment: Talin F2F3 domain and PIP2(C8) interaction 
 
 
Figure 7. Appendix 2. Overlay of 1H-15N HSQC spectra of Talin F2F3 and 
PIP2C8) titration. Black- HSQC Talin F2F3 free, red – Talin F2F3 and PIP2 
at 1:1 molar ratio. 
The interaction between Talin F2F3 and PIP2(C8) is shown in figure 7. The protein 
precipitates after 1:1 molar ratio of F2F3 and PIP2(C8). The chemical shifts are very 
small compared to Talin F3 itself.  
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